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ABSTRACT

Radiation therapy accounts for treatment of over one million cancer patients each year in the
United States alone, and its use will continue to grow rapidly in the coming years. Recently,
many important advancements have been developed that greatly improve the outcomes
and effectiveness of this treatment technique, the most notable being Intensity Modulated
Radiation Therapy (IMRT). IMRT is a sophisticated treatment technique where the radiation
dose is conformed to the tumor volume, thereby sparing nearby healthy tissue from excessive
radiation dose. While IMRT is a valuable tool in the planning of radiation treatments, it is
not without its difficulties. This research has created, developed, and tested an innovative
approach to IMRT treatment planning, coined Direct Compensator Profile Optimization
(DCPO), which is shown to eliminate many of the difficulties typically associated with IMRT
planning and delivery using solid compensator based treatment. The major innovation of this
technique is that it is a direct delivery parameter optimization approach which has adopted
a parameterized surface representation using Non-Uniform Rational B-Splines (NURBs) to
replace the conventional beamlet weight optimization approach. This new approach brings
with it three key advantages: 1) a reduced number of parameters to optimize, reducing the
difficulty of numerical optimization; 2) the ability to ensure complete equivalence of planned
and actual manufactured compensators; and 3) direct inclusion of delivery device effects
during planning with no performance penalties, eliminating the degrading fluence-to-delivery
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parameter conversion process. Detailed research into the affects of the DCPO approach on
IMRT planning has been completed and a thorough analysis of the developments is provided
herein. This research includes a complete description of the DCPO surface representation
scheme, inverse planning process, as well as quantification of the manufacturing constraint
control procedure. Results are presented which demonstrate the performance and innovation
offered by this new approach and show that the resulting compensator shapes can be
manufactured to nearly 100 percent of the designed shape.
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CHAPTER 1
INTRODUCTION

Radiation therapy is a widely used and highly effective technique for the treatment of
cancer, however the commissioning and delivery of a course of external beam radiation
is a complex process subject to numerous challenges.

It is the intent of this research

to develop new innovations that act to improve both the planning and delivery of this
cancer treatment technique. Specifically, this research develops a new approach for solid
compensator intensity modulated radiation therapy planning coined, Direct Compensator
Profile Optimization (DCPO). The following research report will detail the development and
verification of this unique approach, as well as demonstrate its effectiveness by comparison
to current state-of-the-art planning techniques.
In order to understand the benefits and implications of the Direct Compensator Profile
Optimization approach, a reasonable understanding of the field of radiation therapy is
needed. Therefore, Chapters 2 & 3 provide a thorough discussion of the history and relevant
background information in the area of radiation therapy. Chapter 2 is devoted to providing
a short history of radiation therapy. This history should bring to light the competing
goals of radiation treatment while also highlighting numerous improvements that have led
to development of the latest radiation therapy procedures. Appropriately, Chapter 3 will
then complete the groundwork with a discussion of Intensity Modulated Radiation Therapy
(IMRT), which is an advanced delivery and planning technique used in modern radiation
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treatment. It is intended that these two chapters are detailed enough so that the remainder
of this research may be followed by those without existing experience in the field of radiation
treatment planning. Following this background information, the specific details of this new
approach will be presented in Chapter 4, including a concise hypothesis statement. As
this work offers improvements in several different areas which combine to provide a unified
approach that simplifies and improves both the planning and delivery of radiation therapy,
Chapter 4 is divided into several appropriate sections. Each of these sections thoroughly
details a particular research development and clearly demonstrates its place within the stateof-the-art of the field. After this description of the research methodology, Chapter 5 continues
the research developments by providing details of the initial performance testing process.
This initial testing provides the data necessary for a thorough discussion and analysis of
the competing schemes outlined in Chapter 4, so that the most appropriate approaches
may be identified and adopted. Presentation and discussion of the manufacturing constraint
determination process is then undertaken and finally Chapter 5 concludes with a concise
description of the final Direct Compensator Profile Optimization process. The benefits
of DCPO are then quantified by presentation of several example problems in Chapter 6.
These examples demonstrate the application of these techniques within the context of a
basic radiation treatment planning system, developed specifically for this work. These
examples include comparison to current state-of-the-art planning techniques for realistic
patient geometries. This report then concludes with a thorough discussion of the observations
and findings of this research effort in Chapter 7, including final remarks regarding avenues
of exploration for future research within the field.
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CHAPTER 2
HISTORY OF RADIATION THERAPY

External beam radiation has been used as a treatment for malignant disease almost since
the discovery of the x-ray by Roentgen in 1895, with clinical treatment tests well underway
within one year of this discovery. Radiation therapy has progressed a long way from these
initial treatments and today the process of treatment involves determination of a well defined
treatment plan along with finely tuned delivery procedures. This is not to say that the process
is perfect as many patients still experience undesired complications and side effects as a result
of radiation treatment. In order to appreciate the difficulties of radiation treatment and to
arrive at a point where a description of the latest techniques is appropriate, a short history
of external beam radiation therapy is necessary. As the purpose of this history is to provide
a practical understanding of radiation therapy, an example patient and treatment will be
used throughout the chapter. This example will involve treatment of a spherical abdominal
tumor as this is representative of a very simple patient, yet will prove useful to facilitate a
practical and application driven understanding of this history.
The earliest forms of radiation treatment typically involved simple exposure to a fixed
strength beam, often to a wide area of the patient’s body. While these treatments did
provide some benefit to patients, the low levels of tumor dose were often insufficient to offer
a complete cure to most patients. Additionally, many researchers in the field quickly learned
the downside of such treatments, as many patients (and the researchers themselves) often
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suffered from severe radiation poisoning or burns. Researchers and oncologists thus realized
that they could only provide a useful treatment by shielding normal tissue from exposure
as much as possible, while at the same time providing sufficient dose to destroy the tumor
cells (this goal forms the foundation of the field of radiation therapy as a curative cancer
treatment). Early forms of shielding often utilized lead sheets or plates laid directly on the
patient, a practice which still exists for certain types of treatment today.
These shielding practices did allow for simple, two-dimensional control of the radiation
dose, clearly limiting radiation exposure for much of the adjacent area and a majority of
the body. However, this type of “shaping” of the radiation field does not account for the
variation of dose with depth inside the patient. Using the abdominal tumor example, suppose
that treatment is attempted using a single radiation beam placed directly above the patient,
with the patient laying flat on their back. When viewing down the beam’s axis (viewing the
patient from above) it is clear that a lead shield with a circular hole above the tumor will
limit the dose to the desired spherical tumor region as much as possible. However, shifting
to a view perpendicular to the beam’s axis (viewing the patient from the side) and looking at
a two-dimensional slice through the center of the tumor, the dose field shown in Figure 2.1a
is observed. Such a figure is referred to as an isodose (constant dose) plot and it illustrates
the variation of the delivered dose with depth inside the patient’s body. It should be noted
that radiation dose fields such as this are generally displayed in terms of relative dose and
are normalized so that a value of 100% occurs at the location of maximum dose (or at the
isocenter, as will be seen later for multiple beam treatments). Combining these two views
shows that the actual three-dimensional dose is being confined to a cylindrical portion of
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the patient’s body (although the tumor is spherical), the tumor dose is highly non-uniform,
and depending upon the location (depth) of the tumor, the maximum dose is not necessarily
within the tumor region. This results in a relatively poor radiation treatment as normal
tissue receives significant dose and the tumor coverage is difficult to control. Typically, the
only means for controlling this depth dose distribution (and therefore the tumor dose in this
example) is to vary the energy (quality) of the radiation beam. Unfortunately, this offers
little control over the general shape and in practice really only allows adjustment of the
location (depth) of maximum dose. Therefore, another means needs to be found if the dose
is to be further “shaped” to the tumor volume.
The next historical progression came as an attempt to alter the dose distribution with
depth and involved the use of beam modifying devices; often metallic wedges. The dose
distributions which can be achieved using two common wedge designs are shown in Figures
2.1b & 2.1c. While these modifying devices do increase dose control to some degree and prove
useful for certain tumor shapes and locations, in the hypothetical spherical tumor example
they provide little solution improvement because control over the depth of maximum dose
is still not possible.
The next advancements came as researchers found that significant dose shaping could
be achieved by using multiple treatment beams. The most common initial attempts utilized
parallel opposed beams. Simply put, this means using pairs of beams which enter the patient
exactly opposite of one another. A sample dose field from four such equally spaced beams
(two horizontal and two vertical) is shown in Figure 2.2. Inspection of this figure shows
that such a treatment allows the high dose region to be confined to a small box shaped
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area around the tumor. An important observation regarding the dose within this box is the
relative uniformity of dose that is achieved within the region, meaning that the majority
of the tumor will receive an almost equal dose (assuming the entire tumor is within this
region). This achievement was a monumental step forward and practitioners soon began to
vary the treatment angles and number of beams in order to achieve even more conformal
dose distributions.

(a) Open Beam

(b) 30o Wedged Beam

(c) 45o Wedged Beam

Figure 2.1: Isodose Contours for Single Beam Treatments

Figure 2.2: Relative Dose Field for Four Parallel Opposed Beams
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Despite all of these advancements, the problem of conforming dose to a simple spherical
tumor, has still not been fully addressed, as parallel opposed beams are generally limited
to providing high dose to geometric regions with sharp, crisp corners such as rectangles,
diamonds, and hexagons (10-12 beams would need to be used to begin to achieve a roughly
circular shape, however this large number of beams greatly increases the time and expense of
the radiation treatment). Two solutions were developed to solve this deficiency: rotational
(arc) therapy and three-dimensional conformal radiation therapy (3DCRT). Both techniques
remove a major downside of the existing parallel opposed beam treatments: the presence of
significant overlapping of the beams outside the tumor (target) volume. Removing these
overlapping regions allows the magnitude of the normal tissue dose to be significantly
reduced, although this comes at the expense of spreading dose over a wider range of the
nearby normal tissue. This is generally a very worthwhile trade-off and reduced clinical
complications are usually observed for such treatments. The idea behind the first solution,
rotational therapy, is simple: treat from every possible angle. This became possible with
the development of electronically controlled delivery machines (a discussion of the delivery
technology will be undertaken shortly). Once the delivery mechanism could be precisely
controlled, it became possible to rotate a uniform strength beam around a stationary patient,
thereby creating a dose field which contains a nearly cylindrical region of uniform high dose
at the rotational center (isocenter). A schematic representation of this high dose region is
shown in Figure 2.3. Additionally, by controlling the size and shape of the treatment beam
this region can be made larger or smaller and can approach a spherical shape (using a round
rather than rectangular beam opening).
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Figure 2.3: Sketch of High Dose Region for Standard Rotational Therapy
At first glance, rotational therapy may seem like the most ideal solution to conforming
high dose regions and spreading normal tissue dose, but 3DCRT incorporates an extra mechanism of control that provides the ability to achieve more complicated dose conformation. By
adding control over the size and shape of each treatment field, 3DCRT allows for exceptional
dose conformity without the need for a more sophisticated delivery mechanism. This process
uses a small, odd number of fixed angle treatment beams (often 3, 5, or 7) in order to allow
more specific control of the shaping parameters as compared to rotational therapy. The
process of 3DCRT is illustrated in Figure 2.4. This figure shows that each beam is shaped
specifically according the geometric projection of the tumor in the beam axis direction and
results in a beam that is reasonably well shaped to the tumor volume. Once again it should be
apparent that such shaping is based only on a two-dimensional view and does not account for
the variation of the dose with depth inside the patient. However, shaping each beam to the
“correct” geometric configuration confines the overlapping region of the multiple beams much
more closely to the actual tumor volume, thereby achieving a nearly uniform high dose in that
volume. Application of this process was a major milestone in the history of external beam

8

radiation therapy, but required an experienced and skilled physicist/dosimetrist (and a lot of
time) to develop quality treatment plans as the effects of various angles, shaping parameters,
beam weights, and also wedges had to be assessed “by hand”. Advancements in computer
technology soon allowed this tedious planning process to be aided by specially designed
computerized treatment planning systems (TPS). However, adjustment of the parameters
and evaluation of the resulting plans was still largely the task of the cancer treatment team.

Figure 2.4: Three-Dimensional Conformal Therapy
The benefits of computerized planning were astonishing and numerous researchers immediately attempted to improve their treatment plans by developing automated numerical
optimization procedures for determining planning parameters. It was then discovered that
even greater plan control could be gained by allowing an extra degree of freedom (variability)
within the numerical optimization procedure: the variation of intensity within a single
treatment beam. This allowed the elimination of wedges and missing tissue compensators
and was the start of the age of Intensity Modulated Radiation Therapy (IMRT). This process
is quite complex and the next chapter is devoted solely to the details of this breakthrough
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technique. However, before moving on to IMRT a description of the traditional radiation
delivery devices and machines will first be provided to conclude this chapter.
The historical developments described above focused largely on the planning of radiation
treatment procedures. However, it is important to note that even with such sophisticated
planning processes, treatment would not be possible without today’s modern equipment. The
equipment needed to complete a treatment of radiation therapy is not limited to the radiation
delivery devices themselves and also includes patient immobilization devices, medical imaging
devices, and dose measurement instrumentation. These additional needs become apparent
as one reflects upon the idea of dose conformity, and how the accuracy and effectiveness
of the entire process relies heavily upon accurate medical imaging and patient positioning.
Therefore, the important inventions that led to improvements in radiation therapy include
delivery devices such as the linear accelerator, as well as other technologies such as MRI and
CT imaging.
Initially, delivery of radiation therapy involved exposure to radium filled tubes. The
strength of these initial radiation treatments was not great enough to provide useful treatment for anything but superficial cancers. However, it was soon discovered that small tubes
could be surgically implanted into the cancerous tissue allowing for the treatment of more
deep seated tumors, a process called brachytherapy which still exists today. However, since
many patients are too weak to undergo surgery or their tumors are too close to vital organs to
operate, this is not the ideal solution for every patient. Therefore companies such as General
Electric soon developed higher energy tubes which allowed external beam treatment of a
wider range of disease. By the mid 1930’s research had lead to the development of radiation
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tubes reaching an energy of 1MeV [1]. These initial radiation devices all relied upon natural
mined radium as the primary radiation source. One of the first major advancements came
with the development of

60

Co (an isotope of Cobalt containing a total of 60 neutrons and

protons, pronounced Cobalt 60) treatment units in the early 1950’s. These devices utilize
synthetic

60

Co and produce radiation with a maximum energy near 1.2MeV. These

60

Co

machines are essentially the precursor to today’s modern delivery units. The success of
these machines at treating deep seated tumors led to development of the modern isocentric
form for treatment units (isocentric refers to the ability of the treatment head to rotate
around a fixed point in space, so that patients can be treated from many different angles
as needed). Since the establishment of this isocentric device little variation has occurred in
the overall delivery unit configuration and the physical similarities between 60 Co devices and
modern delivery units are quite substantial (see Figures 2.5 & 2.6).
The next major breakthrough came with the invention of the linear accelerator, which
is a device that propels charged particles through a vacuum tunnel into a heavy metal
target. This target absorbs the particles energy and releases high energy x-rays as a result.
This breakthrough was more of a technological advancement and did not initially generate
major changes to the treatment and delivery approaches used for radiation therapy. In
addition to no longer requiring a fixed radiation source material, another major benefit of
the linear accelerator (linac) is its capability to generate very high energy x-rays (18MeV is
commonplace), which improves the ability to treat very deep lesions (higher energy increases
the penetrating power of the beam, increasing the depth of the location of maximum dose).
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Figure 2.5:

60

Co Therapy Unit (image courtesy of .decimal, Inc. [2])

Figure 2.6: Linear Accelerator (Varian Medical [3])
The major benefits of these improved delivery devices were not fully realized however
until medical imaging technology made similar advancements. The proliferation of computer
technology and the invention of Computed Tomography (1971) are possibly the greatest
innovations to affect the field of radiation therapy. These two tools allowed physicians
to precisely locate the cancerous tissue without surgery and contributed immensely to the
success and growth of the radiation therapy field. Accurate imaging combined with high
energy linacs form the basic package utilized for modern radiation delivery.
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CHAPTER 3
INTENSITY MODULATED RADIATION THERAPY

The previous chapter provided a brief journey through the advancements made in the field
of radiation therapy, specifically for the treatment of cancer. The discussion thus far has
emphasized the stages of improvement that treatments have undertaken and has laid the
foundation needed for discussion of a highly sophisticated approach to radiation treatment
known as Intensity Modulated Radiation Therapy (IMRT). This chapter begins with a
detailed overview of the IMRT process, departing from the point where it become a natural
extension of the previous treatment approaches. After a description of the general aspects of
IMRT, details regarding the specific delivery mechanisms currently employed in treatment
clinics is presented. Finally, this chapter concludes with a discussion of the challenges and
difficulties associated with IMRT treatment planning and delivery which provides insight
into the areas of deficiency that this research addresses.

3.1

IMRT Overview

Like many scientific and medical innovations, IMRT is a natural extension of past developments. As with any radiation treatment process, the goal of IMRT is to provide a lethal
radiation dose to the cancerous cells with as little normal tissue dose as possible. Numerous
references provide complex descriptions of the entire IMRT process, see [4, 5] for example,
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however, a much more basic description will suffice herein (a simple, concise description of
IMRT is provided by Webb [6] as well). Essentially, IMRT is an extension of the 3DCRT
process, whereby further dose conformity is achieved by allowing additional variation of the
beam delivery parameters. Specifically, the added variables (degrees of freedom) come from
allowing individual beam intensities to vary, shown schematically in Figure 3.1. This simple
sketch shows how the individual beam strengths may be modulated in order to conform
the region of high dose to the planning target volume (PTV), which includes the tumor and
necessary margins to account for uncertainties, while limiting the dose to the adjacent organat-risk (OAR). IMRT necessarily has become a complex process, because addition of this
extra variability precludes the possibility of simple “forward planning” by hand as used in
3DCRT. IMRT treatment plans must be developed using a process called “inverse planning”,
which is essentially a numerical (computerized) optimization process where numerous plans
are compared (in an intelligent manner) in order to obtain the best possible dose conformity.

Figure 3.1: Two-Dimensional Intensity Modulated Beam Profiles
Understanding all the details of the IMRT process can be a daunting task, especially
when one discovers the large body of research currently being conducted in the field. While
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reviews of this literature are readily available from authors such as Webb [7, 8], only a few
papers, see [6, 9, 10] for instance, are truly needed to provide the level of understanding
necessary for the majority of those in the field. Along with the huge body of literature, the
importance of this technique in the fight against cancer is further evidenced by the fact that
over one million cancer patients are treated with external radiation in the U.S. each year [11].
This ever growing number stems from reduced treatment complications and increased cure
rates that are often associated with IMRT. As this work aims to improve the planning and
delivery of IMRT, further details of the IMRT process, including a description of the inverse
planning procedure, are given below. Finally, the discussion of IMRT herein, is completed
by a thorough comparison of the two most common delivery techniques.
While IMRT is a powerful tool in the treatment of cancer, it is not necessary or ideal
for all cancer cases and the decision for use of this technology lies in the hands of trained
medical professionals, typically the attending physician or a qualified medical physicist.
Once the decision to treat using IMRT has been made, the process will start by setting
the patient into a specific treatment position (utilizing various fixation devices as needed,
including vacuum formed masks, hold downs, bite plates, and other patient specific devices)
so that consistent treatment can be achieved. Once an appropriate position has been found,
the patient skin is semi-permanently marked so that re-alignment can occur in a precise
manner. Medical images of the patient are then obtained in this treatment position using
either computed tomography (CT) or magnetic resonance imaging (MRI) technology. The
images are digitally recorded and the patient is no longer needed until treatment planning
is completed and delivery is ready to commence. The treatment planning team (physician,
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physicist, and dosimetrist) will use the images to determine a patient specific treatment
plan. Development of this treatment plan begins with the physician outlining the critical
anatomical structures on the digital patient images, a process referred to as contouring.
Contouring is used to delineate the planning target volume (PTV), which consists of the
visible cancerous tissue as well as an appropriate margin to account for unseen microscopic
disease, from the healthy normal tissue. Additionally, depending upon the location and
extent of the disease, vital organs such as the heart, bladder, brain stem, or spinal cord, may
be contoured so that radiation dose may be further limited in these organs-at-risk (OARs).
Figure 3.2 shows contouring of a single CT slice for a typical prostate cancer treatment setup.

Figure 3.2:
Typical IMRT Patient Contours and Prescription (adapted from
http://www.radonc.uchicago.edu [12])
The oncologist then completes their part in the contouring phase by providing an
appropriate prescription for each of the outlined structures. These prescriptions may be
a range of acceptable dose levels in the case of a PTV, or in the case of an OAR a maximum
dose or dose-to-volume constraint; in addition to the contouring of critical structures an
example prescription can also be seen in Figure 3.2. This prescription serves as the constraint
needed to perform the inverse planning optimization process. Next, the patient contours are
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converted into a discrete set of points (voxels) to facilitate numerical calculation of the dose
field and comparison to prescription values on a point-by-point basis. This is important
as the remainder of the planning process is largely automated relying upon numerical dose
calculation and optimization routines. The computerized treatment planning system, the
foundation of which is simply a combination dose calculation and optimization engine, then
adjusts the treatment parameters and compares the resulting dose field to the prescribed
values until an optimal (or acceptable) plan is reached. While it is possible to include
parameters such as beam number, beam angle, and beam energy into the optimization
process [13, 14, 15, 16], such functionality is generally considered an academic exercise as
the extra planning time is not justified by the slight increase in plan qualities that are
obtained. Thus, the planner will often directly choose the number of beams for treatment
as well as the energies and angles, with odd numbers of equally spaced, coplanar beams (5,
7, or 9) being the most common treatment setups. A typical five coplanar beam setup is
illustrated in Figure 3.3. Each treatment field is generally a rectangular shape and the size
is often determined using a simple projection of the PTV onto a beams-eye-view (BEV) for
each treatment angle. This beam setup information is entered into the treatment planning
system, leaving only the intensity level variation for each beam as the remaining unknown
to be identified by the numerical optimization routines.
Description of the beam intensity profiles is typically accomplished in a discrete fashion
whereby each treatment beam is discretized into beamlets; a beamlet being a small rectangular portion of a single beam. Optimization then consists of determining the best weight
for each beamlet so that the prescribed dose is adequately matched and conformation to the
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PTV obtained. The beamlet weight can be regarded as a blocking factor for the individual
beamlet, with a weight of 1 indicating the beamlet is unblocked and 0 indicating that it
is fully blocked (although in some cases a relative weighting is used so that values above
1 are permissible). A schematic of a set of optimized beamlet profiles and the resulting
relative dose field (for a single two-dimensional slice) is shown in Figure 3.4. Finally, the
planning stage is completed by converting the optimized beamlet weights into the necessary
parameters for the chosen delivery modality.

Figure 3.3: Typical Coplanar IMRT Beam Arrangement (Five Beams shown)

Figure 3.4: Optimized Beamlet Profiles with Corresponding Relative Dose Field
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3.2

IMRT Delivery

Delivery of IMRT is accomplished by either spatial fluence (dose rate) variation via a
solid modulating/compensating filter (commonly referred to as a solid compensator) or by
temporal variation of fluence (time-varying) via a Multi-Leaf Collimator (MLC) device. A
solid compensator achieves fluence variation by placing a block of certain thickness directly
in the path of the beam. In regions where the block is thick, the beam intensity reaching
the patient is greatly reduced, while in regions where the block is thin the beam intensity
remains almost unchanged (a typical solid metal compensator is shown in Figure 3.5a).
In contrast, the MLC accomplishes the fluence variation by opening different areas of the
beam for different lengths of time. Put another way, the MLC always turns the beam on to
“full strength” and simply varies the exposure time to each area to accomplish the required
modulation. If a large dose is required in an certain area, then the area will be exposed for
a long time. However, if an area of the field requires a smaller dose, the MLC leaves are
adjusted (these leaves are electronically controlled to position themselves into the necessary
field shapes during the course of the treatment), so that this area is blocked during a portion
of the beam-on time, thereby reducing the dose that this area receives (a standard 80 leaf
MLC is shown in Figure 3.5b).
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(a) Solid Compensator

(b) Multi-Leaf Collimator

Figure 3.5: Comparison of IMRT Delivery Devices (images courtesy .decimal, Inc. [2])
The compensator is actually an older modulation technique, which has largely been
replaced by the multi-leaf collimator in the United States, but the solid compensator is
beginning to see a resurgence in clinical usage due to new research findings. Before explaining
such findings and describing the motivation for focusing this work on compensator based
treatment, a thorough comparison of the two techniques is needed. The brief descriptions
above should have shown that the MLC is obviously a step forward in technological terms
compared to the solid compensator, as the MLC provides a means of treating all patients
with a single movable device. However, this technological advancement does not necessarily
translate into additional treatment capabilities or improved clinical outcomes. In fact, there
are generally only four points that one may raise in favor of the MLC:
1. ease of clinical use
2. immediate availability
3. environmentally more favorable
4. increased clinical safety
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The first point is an unarguable truth and one which compensator based treatment could
never surpass due to the patient specific nature of radiation treatments. Due to the unique
size and shape of each patient and their tumor(s) a specific solid compensator must be
manufactured and placed in the treatment delivery unit for every patient (actually several
are needed per patient as most are treated from multiple angles). However, this point should
really have no grounds for justifying clinical usage of a device, as ease of use has no direct
correlation to clinical outcomes or effects. The only possible benefit that this advantage
could provide is decreased operational costs or times, thereby allowing treatment of more
patients at reduced expense. However, recent retrospective studies [17, 18, 19] have shown
that the reverse is actually true, with MLC delivery leading to increased costs due to large
up-front expenses, higher maintenance costs, greater down times, and longer beam-on times.
The second point raised in favor of the MLC is that a single MLC is able to treat any
patient due to the presence of the movable leafs, and because commercial planning systems
can interface directly with the MLC control system, allowing the prescribed treatment plan
to be immediately delivered through the MLC for each patient. This advantage has been
greatly reduced in recent years, due to rapid growth and automation within the manufacturing industry, and two viable paths exist to allow nearly immediate treatment using solid
compensators, thereby matching the capabilities of the MLC. Some clinics employ an inhouse manufacturing center to create the custom compensator devices, while others utilize
mail-order compensator manufacturing services. Mail-order services eliminate the need for
a clinic to staff, maintain, and oversee a manufacturing facility and have recently gained
popularity. Companies such as .decimal, Inc. have greatly stream-lined the manufacturing

21

process and offer 12-24 hour turn-around times on compensator fabrication and delivery,
making the difference between compensators and MLCs practically irrelevant in this respect.
The third point seems quite sound at first glance, however a deeper look into the
operating, manufacturing, and maintaining of the MLC is needed before a true claim of
superiority is possible in this regard. This author is unaware of any study to-date comparing
such issues. Also, with recent advancements in recycling practices, compensator materials
can be conserved and re-used with a high level of efficiency.
The fourth and final point regarding clinical safety is one that stems from concerns
regarding the installation of the compensators in the linear accelerator head by the radiation
therapist before each treatment. It is possible that a block may be installed improperly
or that the wrong block may be used, however similar concerns regarding the loading
of a wrong plan into the MLC control system can also be raised.

Each compensator

also contains an indexing feature which prohibits installation in the wrong direction. An
additional safety concern is that of therapist and patient injury due to dropping a large heavy
compensator (some may weigh up to 20 pounds) or due to the exertion of the therapist in
loading numerous heavy blocks day-after-day. Once again however, this point offers a rather
improper justification for the use of MLCs over compensators as these issues can be mitigated
by proper care on behalf of treatment professionals.
The overall theme for the motivation to use MLC based treatment has been shown to be
its ease of use. This attitude is clearly evident in the field with well respected texts such as
that of Khan [4] advertising the MLC as such, stating, “the impact of this [MLC] technology
is in the automation of field shaping and modulation . . . ,” and dismissing compensators
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because, “carrying so many heavy blocks, patient after patient, creates a nuisance for
therapists who have to guard against dropping a block accidentally or using a wrong block.”
Although this discussion has demonstrated that the MLC has no significant advantage over
the solid compensator, it has not established any real motivation for increasing compensator
usage by proving that compensators actually provide clinically relevant benefit. There are
several key points that can be raised in this regard, namely:
1. compensators can provide increased spatial dose resolution
2. compensators provide more consistent dose
3. compensators impose no limitations on the dose delivery rate
4. compensators reduce skin surface doses
The first point is addressed by noting that the spatial resolution of an MLC is always limited
in one direction by the available leaf width size. A two-dimensional, beams-eye-view of the
MLC as shown in Figure 3.6 illustrates this resolution concern. It can be argued that this
is a device resolution concern, which will not translate directly to delivered dose differences,
however, experiments [2, 20, 21] have shown that the dose resolution is indeed degraded for
an MLC. The level of spatial degradation is apparent by inspection of Figure 3.7, which shows
the fluence distribution achievable for both an MLC and solid compensator when attempting
to produce a radially symmetric ring of high fluence (shown in white) while maintaining low
fluence in the outer and central regions.
The second point regarding consistency of delivered dose by compensator treatments
stems from the fact that most compensators in clinical use are made from solid metallic
materials and contain no moving parts. This fully static nature of the compensator eliminates
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some of the day-to-day variability of the treatment as the fluence modulation produced by
the compensator is completely repeatable and constant for every treatment fraction. This is
important to emphasize, due to the fact that MLC delivery does contain some slight day-today variability due to statistical variation in the operation of the electronic leaf motion control
system. While this may not be a noticeable issue for most treatments, it is a major concern
when failure occurs (i.e. leaf sticking or seizing or another operational malfunction) as this
causes severe errors in delivered dose. An even more important benefit of compensator dose
consistency results from the way in which the modulation is accomplished. Compensators
provide a true fluence modulation as they adjust the beam strength in a spatial manner,
whereas an MLC provides an indirect fluence modulation by varying the exposure time only,
not the beam strength. This has great relevance on received dose for moving organs and
tumors [22] even with a properly drawn PTV which includes margins to account for tumor
motion. Figure 3.8 shows the high dose region (shaded pink area) at three separate times
for both compensator and MLC delivery. The clinical target volume, CTV, (i.e. the actual
cancerous tissue volume) is shown shaded green and the extents of the motion are shown by
the dashed curves. This figure provides a clear observation that the temporal modulation
of the MLC can lead to improper dosing of the tumor as the high dose region changes
throughout time. An excellent description and quantification of this issue is also given by
Bortfield et al [23]. As also shown in this figure this does not occur with compensator
treatments as the high dose region is constant throughout the entire treatment time (for
each beam).
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Figure 3.6: Beams-Eye-View of Standard MLC Showing Stair-Case Resolution Issue

(a) Compensator Delivery

(b) MLC Delivery

Figure 3.7: Delivered Dose Resolution Comparison (.decimal, Inc. [2])
The third claim relates to a recently developing benefit which appears due to the
necessity of MLC leaf motion. The maximum leaf speed of a given MLC machine is a finite,
fixed value which is actually the current factor limiting the dose delivery rate on modern
linear accelerators. Put more simply, the leafs cannot move fast enough to keep up with
the delivery rate of modern equipment. Therefore, the output dose rate must be reduced
in order to allow MLC treatment to succeed. Compensators have no inherent limitation in
this regard and will always allow machine maximum dose rates to be used. This benefit
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allows patients to spend less time on the treatment table, thereby experiencing less fatigue
and feeling less stressed by the procedure. This increased dose rate also translates directly
into reduced beam-on times, which reduces power consumption and lowers the wear-and-tear
placed on the linear accelerator devices, especially for quality assurance, QA, testing (proper
QA for MLC requires a full, real time simulation in order to ensure proper temporal dose
variation, whereas compensators require only enough simulation time to ensure accurate dose
measurements are achieved as fluence is modulated spatially, not temporally).
The final point listed above occurs due to the low energy filtration that high density
compensator materials provide (this is referred to as beam hardening and will be discussed
in detail in the following chapter). This filtration removes a large percentage of the low
energy photons, thereby increasing the skin sparing effects of high energy IMRT treatments.
Experiments by Jiang [24] and more recently by Stathakis [25] have shown a 5%-10%
reduction in skin dose for many patients, with some receiving reductions as high as 40% when
compensator treatment is used over MLC. Each of these advantages is significant enough
to justify an increase in compensator based treatments, as they all have the potential to
provide actual clinical benefit, therefore the clinical need for improved compensator based
treatment planning is quite large.
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PTV
CTV
Range

(a) Treatment Contours

(b) Compensator Based Treatment

(c) Multi-Leaf Collimator Based Treatment

Figure 3.8: Impact of Tumor Motion on Delivered Dose
On a final note, a patient survey was recently undertaken by Yaeger and Cost [26],
where a sample of clients from their treatment facility were polled, all of which received
IMRT treatment at the same facility, under the same treatment staff. The results of this
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poll showed that of all patients receiving MLC IMRT less than 50% were satisfied with their
treatment, whereas 100% of those receiving compensator based treatment were satisfied
with the procedure. It should be understood that this survey takes no account of clinical
outcomes or treatment success, and is simply patient opinion. Those authors claim that this
100% satisfaction rate comes from the increased human interaction given to those receiving
compensator based treatment. Such interaction was not purposeful to skew the data, it was
simply commonplace for the therapist to check on the patient while they entered the room
to manually change the compensator after each treatment angle. Since MLC delivery does
not require such a manual change, the clinician generally does not enter the treatment room
between portals so patients receive less interaction and are generally more anxious during
the process. This study and the clinical benefits described above naturally bring about the
conclusion that available technology for compensator based treatment forces an increase in
perceived treatment quality, while simultaneously providing an actual increase in treatment
quality.

3.3

IMRT Challenges

Radiation therapy is a complex field with significant treatment challenges. Much of the
difficulty stems from the competing objectives of radiation therapy: 1) deliver a lethal
radiation dose to the cancerous tissue and 2) provide non-harmful radiation dose to healthy
tissue. Meeting these goals is difficult because radiation therapy is a non-invasive technique,
which requires the radiation beam to pass directly through healthy tissue in order to reach
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the tumor seated inside the patient’s body (this allows it to be used without requiring
dangerous or difficult surgery). Additionally, the tumor is typically not large enough or dense
enough to absorb all of the incoming radiation, so tissue beyond the tumor will also receive
some exposure. Clinicians and researchers developed IMRT as a sophisticated technique for
balancing the two competing treatment goals by conforming radiation dose to the tumor as
closely as possible, which has been widely shown to maximize treatment efficacy. However,
even with IMRT there are difficulties that still exist and areas which could benefit from new
innovation.
One particularly difficult aspect of IMRT is the inverse planning process. Recall that
inverse planning is the process by which the necessary treatment parameters are determined
such that an acceptable dose field is achieved. This process is difficult for many reasons,
but one notable area is the representation of the intensity modulation. As described in
Section 3.1, the modulation of the fluence is most often accomplished numerically by use of
small individual beamlets. Many beamlets will exist for any useful plan (typically several
hundred per beam), making the optimization process challenging due to weak parameter
correlations and low parameter interaction and sensitivity. Further details of these inverse
planning concerns are provided in the following chapter as they pertain to the specific details
presented therein.
A more recently emphasized area of concern with IMRT is tumor localization. Numerous studies have shown that tumor motion due to respiration and digestion processes can
have significant effects on the location of the tumor at any given time. Digestive system
concerns such as stomach, bladder, and bowel fullness can cause day-to-day variability,
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while respiratory motion of the diaphragm and lungs can cause continuous variability in
tumor location. These concerns are particularly poignant for IMRT since the dose is highly
conformal; therefore a small error in tumor location can lead to a miss in the delivered
dose [22]. Ehler, Nelms, and Tome [22] have shown that using compensators for treatment
of moving tumors can increase dose uniformity and clinical effectiveness. They concluded
that the static nature of the solid compensator simplifies the delivery process for such cases
and is a key ingredient to its success. Additionally, Markman et al [27] have shown that
producing smoother fluence modulation profiles results in decreased sensitivity to patient
positioning errors. Since a positioning error is analogous to an internal motion error, their
work also pertains to the case of tumor localization concerns. Direct Compensator Profile
Optimization is designed to increase the smoothness of the compensators for manufacturing
considerations, therefore this will have the beneficial side effect of reducing positioning and
tumor motion sensitivity.
A final area of challenge specifically for solid compensator IMRT is that of manufacturing. Manufacturing of solid compensators is generally viewed as the most inconvenient aspect
of their use, but it is obviously unavoidable as each beam requires its own distinct modulation
profile for every patient. Like most parts of the IMRT process, several choices exist for this
step as well. The three most practical approaches include casting, powder/pellet molding,
and CNC milling. Casting and molding are typically accomplished in similar fashion and
each of these processes begins by creating a foam or wax plug, which is the reverse shape of
the desired compensator (the plug may be drilled, milled, or cut to the appropriate shape).
Following creation of the plug, the actual compensator is made by either pouring melted
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material (typically Cerrobend) for casting or packing powder/pellets (often copper, tin, or
stainless steel) for molding into a rectangular box containing the plug [28, 29]. For casting,
the material hardens and can be removed from the box for use. For molding, the packed box
is needed to contain the material, therefore the box itself, complete with the powder and
plug will become the compensator [29]. The third option, milling, is generally performed on
metallic materials, with brass being the most common choice. Milling is generally the most
precise and offers the greatest manufacturing flexibility; it is also the most time efficient as
only a single manufacturing step is required. Because of this single step nature, milling also
offers the highest possibility for automation of the manufacturing process. For these reasons
this work will focus solely on milling for compensator fabrication.
Despite the benefits of the milling procedure as compared to other manufacturing
processes, there are still limitations regarding its use. Specifically, the major difficultly
comes from the fact that manufacturing is not addressed until after inverse planning is
complete. The typical process for the design and manufacture of a radiation compensator is
shown in Figure 3.9. This chart shows the major deficiency, namely, that milling concerns
are not known until after the compensator order has been placed and analyzed. This
problem can cause significant delays in the radiation treatment process, as the treatment
plan must be modified and inverse planning completed again in the hopes of providing a
more manufacturable compensator. This is not an overly alarming concern and informal
estimates from .decimal, Inc. state that this issue affects less than five percent of their
compensators. What is more common however, is that the matching is not poor enough to
necessitate a new plan (due to time and cost considerations), and a mismatch of 3%-5% is
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often accepted. It should be noted that the actual milled surface can be ascertained from the
milling simulation software, so that the expected patient dose can be re-computed, however
these discrepancies generally reduce the modulation range and degrade the plan further from
the “optimal” plan provided by the treatment planning system.

Figure 3.9: Standard Compensator Design and Manufacturing Processes
The remainder of this document describes the Direct Compensator Profile Optimization
process and includes detailed descriptions of how it is able to overcome many of the challenges
presented in this section. In addition, numerous examples are provided to justify the claims
regarding the abilities of the DCPO procedure.
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CHAPTER 4
METHODOLOGY

By now, the process of Intensity Modulated Radiation Therapy should be sufficiently understood so that the characteristics of an ideal treatment planning approach can be discerned
and the major challenges to implementation appreciated. The preceding discussions have
mentioned the areas of deficiency in regards to current solid compensator IMRT treatment
planning, however the work completed herein to resolve these issues has not yet been
thoroughly described. It is the focus of this chapter to provide such a description for
the Direct Compensator Profile Optimization (DCPO) approach. The premise of DCPO
is quite straight forward: generate the treatment plan by directly optimizing the shape of
the compensator surface. The following hypothesis statement highlights the major benefit
that this approach allows:

Direct surface optimization reduces the number of optimization parameters and
allows manufacturing and delivery device limitations to be addressed during the
inverse planning stage. This parameter reduction and manufacturing/delivery
limitation inclusions will increase the computational efficiency of the inverse
planning process, reduce the oscillations along the compensator surfaces, and
increase the agreement between planned and delivered radiation dose, without
affecting the quality of the resulting treatment plans.
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There are several difficulties associated with such a process that must be addressed, the most
important of which is how to describe and control the compensator surface shape. DCPO
utilizes a three-dimensional analytical surface representation to provide a smooth, continuous
representation of the surface profile using a relatively small number of control parameters.
This analytical representation also acts as a unique parametrization of the underlying field
beamlets and avoids the need for direct optimization of the numerous beamlet strength values
(it is this parametrization that provides the many benefits associated with this planning
approach). Since DCPO operates using the actual physical shape of the compensator,
the planning process is able to incorporate two new features which are quite expensive
or impossible to include with other more traditional approaches. First, manufacturability
of the compensator surface can be ensured during planning by appropriately limiting the
surface representation scheme. This guarantees that the planned surface is nearly 100%
machinable, thereby ensuring that the delivered dose matches the planned dose (note that
such an ability is not truly possible without a method that directly optimizes the physical
delivery parameters, as does DCPO). Secondly, dose calculations may now include beam
perturbations caused by the presence of the compensator within the optimization process
as the actual, local material thickness is known at all stages of planning. The incorporation
of these features, the implementation of the surface representation scheme, and important
changes to the inverse planning (optimization) process are described in detail in the remainder of this chapter. The description of each approach also helps to further establish the
relationship of DCPO to current state-of-the-art approaches used for treatment planning.
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4.1

Surface Representation and Beamlet Parametrization

As previously described, almost all current approaches to IMRT treatment planning begin
by dividing each treatment beam into a set of small rectangular beamlets. While the
beamlet size is often adjustable, most practical systems limit resolution between 5 − 10 mm.
Beamlet resolution (size) is important as it is the determining factor in two competing
aspects of treatment planning: dose calculation accuracy and optimization performance.
In terms of dose calculation accuracy, small beamlets are more desirable as it improves the
numerical approximations made within most dose calculation algorithms. As for optimization
performance, since most planning systems use the beamlet strengths directly for inverse
planning (recall that it is the strength of each beamlet that provides the fluence modulation
and facilitates the development of conformal treatment plans), small beamlets are undesirable
as it leads to increased numbers of optimization parameters and reduced sensitivity amongst
the beamlet strengths. It is possible that improvements can be made by allowing for nonuniform beamlet discretizations, but implementation of such an approach has not yet been
shown in the published literature.
An alternative procedure, shown by Markman et al [27], demonstrated a novel interpolation approach which was used to parametrize the beamlet strengths. Parametrization
simply means that rather than varying the strength of each beamlet individually, one instead
varies the values of some “control parameters”. The control parameters are used in some
mathematical relationship to facilitate calculation of the actual strength of each beamlet,
then dose calculations can proceed as usual using the individual beamlet strengths. Such
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a parametrization has several important implications in the planning process, two of which
were well recognized by Markman et al. First, the number of planning variables (degrees
of freedom) can be significantly reduced, so that planning times are shortened. Second, the
resulting plans will generally have smoother fluence fields which reduces some unnecessarily
sharp gradients, thereby decreasing dose errors associated with patient positioning and/or
organ motion. What was missed in this work however, was the applicability of this process
to solid compensator based treatments, as well as the effects of such a parametrization on
the inverse planning algorithms. DCPO utilizes a parametrization approach very similar
to that proposed by Markman, however, DCPO takes the procedure several steps beyond
this previous work by moving the interpolation from fluence to the physical compensator
surface. The process is illustrated for a two-dimensional geometry in Figure 4.1, where the
red dots indicate the control parameters (surface heights in this sketch) the solid black line
shows the resulting surface representation, and the yellow bars indicate the finely discretized
beamlet heights (this sketch provides a view of a single slice of a full compensator, however
it should be noted that this work has developed and verified the DCPO process for full
three-dimensional patient cases).
This type of direct physical delivery parameter optimization has an intuitive simplicity
and the theoretical advantages are quite broad, with the most notable being the elimination
of the secondary optimization step (this process is described below), as well as the possibility
for more accurate agreement between planned and delivered doses (due to inclusion of
delivery device effects during planning). While DCPO is the first procedure of its kind
for compensator based treatments, it is not the first approach which has attempted to use
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physical delivery parameters during the optimization process. Direct Aperture Optimization
(DAO) is a recently developed technique for MLC based treatments that also follows such a
path. DAO trades the ideal fluence optimization for a direct MLC positioning optimization,
thereby removing the time-consuming, plan degrading process of leaf segmentation. DAO
also allows for the incorporation of specific MLC delivery concerns into the planning system
during the inverse optimization stage. Effects and limitations such as leaf width, leaf edge
shape, and inter-leaf leakage can all be included so that dose calculations are improved.
Further benefits of DAO and delivery parameter optimization in general are discussed by Yu
et al [30]. DAO has gained some clinical success through Philips Pinnacle P3 IMRT and their
specific version of DAO referred to as Direct Machine Parameter Optimization (DMPO).
Clinical studies by van Asselen et al [31] have shown that DMPO is able to provide improved
tumor dose homogeneity for breast cancer treatment. Much like DAO and DMPO, this new
process of DCPO allows for the key aspect of delivery device effects to be addressed during
inverse planning with no major computational penalty (in the DCPO approach efficiency
is actually improved). Specifically for compensator based treatments, these delivery device
effects include dose calculation perturbations due to beam hardening and delivered dose
variability due to manufacturability problems. Incorporation of both of these effects will
be addressed in the corresponding sections below, but first a detailed description of the
secondary optimization process is needed.
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Figure 4.1: Two-Dimensional Illustration of Direct Compensator Profile Optimization
Secondary optimizations are often needed in the IMRT planning process due the substantial changes in modulation that occur when the “ideal” fluence (solution from the
optimization routine) is converted to a deliverable fluence. Both MLC and solid compensator
IMRT have specific considerations regarding this conversion from ideal to deliverable fluence.
For solid compensators there are three concerns that necessitate a secondary optimization process for most planning approaches: beam hardening, non-uniqueness of fluence-tocompensator conversion, and manufacturability. Beam hardening makes the calculation of
compensator thickness an iterative process since the attenuation coefficient, µ, is a function
of beam energy and/or material thickness. Therefore, the following equation is used in a
simple iteration loop to determine the appropriate compensator thickness, t, at numerous
positions across the beam (usually at the center-line of each beamlet):
I = Io e−µ(t) t
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(4.1)

where Io refers to the unmodulated beam intensity and I is the desired intensity value
obtained from the ideal fluence map (this applies to both relative and absolute intensity
values).

The exponential behavior of attenuation complicates attempts to smooth the

ideal fluence profile before converting to compensator thicknesses as this may result in
undesirable effects. Thus the most effective way to smooth the compensator is to do so
after conversion to thickness values. Existing programs recognize this and perform such
smoothing after compensator shape generation, however such programs also often include
another overall beam weight optimization after the smoothing in order to help eliminate the
plan degradation resulting from these processes [32]. The second issue regarding the nonuniqueness of conversion is often addressed by an assumption attributed to Jiang [24] which
gives “optimal” compensator designs as those which use the minimum possible thickness to
achieve the calculated ideal fluence modulation. These are optimal is the sense that the
required compensator thickness and beam-on times are minimized. The DCPO approach
avoids this problem altogether since the compensator surface, not the ideal fluence, is
provided by the optimization. This approach also has the benefit that it may allow plans to be
improved due to beam hardening effects. Although substantial effects are not possible from
such inclusion, doses to the skin and superficial tissues may be reduced by an appreciable
extent in some cases. Also, it is understood that such effects come at the expense of increased
beam-on time, however this increase is not significant for the typical ranges of modulation
that are expected in common planning situations.
In order to accomplish the transition to Direct Compensator Profile Optimization, a
means of appropriately describing each compensator surface is required. Numerous schemes
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exist which can be used for this purpose and several were tested by Markman et al [27]
for the case of fluence representation, including polynomial spline and radial basis function interpolations. However, this research has some additional objectives beyond those of
Markman; therefore it is important to take a deeper look at these goals, so that the most
fitting surface representation scheme can be chosen. One important goal is that the planning
process should restrict its efforts to working only with compensator surfaces that are 100%
manufacturable with standard techniques. This restriction quickly provides the additional
constraint that smooth, continuous surfaces are required. Another important goal is to
remove unnecessary surface oscillations so that excessive surface gradients are reduced and
smoother compensators result. Prior experience with parametrization and interpolation by
the author [33, 34, 35] has shown that polynomial regression can provide viable solutions for
noisy (oscillatory) data. However, low order polynomials would not allow representation of
the types of surfaces expected for radiation compensators and high-order global polynomials
are too oscillatory for this application. Therefore, a spline approach rather than global
regression is a better choice. Two approaches are prominent candidates to satisfy the given
objectives: bi-cubic spline and Non-Uniform Rational B-spline (NURB) surfaces.
Bi-cubic spline interpolation is appealing as it satisfies the continuity and smoothness
requirements, while also allowing for reasonably steep field gradients to exist where needed.
Additionally, Markman [27] found this approach to be quite promising in his work. The
process of cubic spline interpolation is well known and provides sufficient smoothness by
enforcing continuity of the field as well as the first and second derivatives at each of the spline
control points. Variation of the surface is accomplished by simply adjusting the heights and
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possibly the horizontal positions of the spline control points. The implementation procedure
for two-dimensional bi-cubic splines is thoroughly detailed in texts such as Numerical Recipes
[36]. Cubic spline and bi-cubic spline surfaces are shown in Figure 4.2 for an arbitrarily chosen
set of control points, so that smoothness and steepness can both be well visualized.

Figure 4.2: Cubic Spline Interpolated Surfaces (1D and 2D)
Cubic spline interpolation does seem to satisfy the major requirements for successful
surface representation, however, upon testing it was found that adequate control over the
maximum and minimum surface heights was not feasible. This problem occurs due to the fact
that the splines are forced to pass exactly through each control point, therefore the surface
is forced to overshoot/undershoot in the neighborhood of steep gradients. The resulting
surface concerns are highlighted by Figure 4.3.

Figure 4.3: Cubic Spline Surface Control Issues

41

Non-uniform rational B-splines use a robust control technique which allows complex
surfaces to be described with fewer parameters than many alternative approaches, making
them an attractive choice for this work. Also, as NURBs are not interpolating functions
they tend to reduce the oscillations as compared to many other polynomial based methods.
Another important property of the NURBs is that they are guaranteed to be bounded
by their underlying control point range [37]. This bounding is a primary motivation for
using NURBs since a useful compensator design must respect limits on both maximum and
minimum surface heights. The surface complexity possible with NURBs is often a desirable
property, however since smoothness and steepness are important concerns of this work, the
NURBs must be sufficiently limited in order to ensure only appropriate surfaces are able to
represented. Therefore, some simplifications have been made to the typical NURB surface
representation so that the available surface complexity is reduced. These simplifications
also allow for a more straight forward parametrization and a more computationally efficient
surface calculation process. The specifics of these simplifications are presented below along
with a brief description of NURB implementation process.
Two-dimensional NURB surfaces are direct extensions of their one-dimensional NURB
curve counter-parts. Therefore, the description of the reduced NURB representation used
herein will be explained for NURB curves and then the necessary extensions for multidimensional surfaces will be directly provided. This discussion will not attempt to explain
the full implementation procedure for NURBs as this exists in numerous references (see [37]
for example). Instead the goal is to discuss the relevant qualities that make NURBs ideal
for this work as well as describe the specific restrictions and reductions used on the NURBs
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herein. A NURB curve typically consists of four major components, a basis function of
specified order, k, a knot vector, X , a weight vector, CW , and a control point vector, CP .
The basis functions, θ, are defined in a recursive manner as:

θ (u, i, k, X) =

(u − Xi ) · θ (u, i, k − 1, X) (Xi+k − u) · θ (u, i + 1, k − 1, X)
+
Xi+k−1 − Xi
Xi+k − Xi+1

(4.2)

for k > 1, while for k = 1:

θ (u, i, 1, X) =




 1 if

Xi ≤ u < Xi+1



 0

otherwise

(4.3)

where k is the order of the NURB curve, X is the knot vector, u is the evaluation point along
the curve, and i is the index of the control point vector. The expression for k = 1 shows
that each basis function is non-zero only over a brief window of the curve. This means that
changes to a single basis function or control point will affect only a small area of the curve,
allowing for fine tuning of localized sections of the curve. Also, since each basis function is
non-zero only over k knots, the spacing of the knot vector values can be used to control the
influence region of each basis function. This is one of the features that makes NURBs so
robust. Techniques such as duplicating knot values can be used to create sharp cusps and
corners or force interpolation if so desired. However, since this work wishes to avoid such
features, a uniformly spaced knot vector will always be used. This proved to be a very useful
restriction for this work, not only due to the concerns just described, but also because the
knot vector must always be monotonic and the resulting NURB curve is very sensitive to even
small changes in the knot vector values. This extreme sensitivity makes surface optimization
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difficult, as even slight changes in the knot vector can lead to significant surface changes.
Additionally, maintaining the monotonicity of the knot vector throughout the optimization
proved difficult to handle well (re-ordering the knot vector to ensure monotonicity can cause
drastic surface changes). Fixing the knot vectors leaves full specification of the NURB curves
directly in the weight and control point vectors. Understanding the purpose of these vectors
is quite straight forward as each has an intuitive physical meaning. Simply put the control
points specify locations at which the curve should approach and the weights specify how
strongly the control point should “pull” the curve toward itself. The role of these points and
weights can also be seen in the expression of the complete NURB curve, which is generally
a parametric relation as shown by:
PN x
q (u) =

i=1


CPiq CWi θ (u, i, k, X)

PN x

i=1

(CWi θ (u, i, k, X))

(4.4)

where q refers to any particular coordinate direction (x, y, or z), CP and CW are the
vectors of control points and weights, respectively, k is the order of the NURB curve, and
N x refers to the number of control points/weights. Figure 4.4 further illustrates the roles of
the points and weights for an arbitrary curve in two-dimensions. The red points show the
control point positions (connected by linear splines for clarity) and the blue line shows the
resulting NURB curve. Note that the control point positions are identical for each curve and
dictate the major trends of the resulting curve. In Figure 4.4a equal weights have been used,
while in Figure 4.4b the lowest point has a significantly increased weight value, which acts
to “pull” the curve toward this point. This figure thus highlights the two different means of
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controlling a NURB curve that are utilized herein: adjustment of the control point heights
and weights.

(a) Equal Weights

(b) Unequal Weights

Figure 4.4: NURBs Curves in Two-Dimensions
There is one final reduction that has been implemented to simplify the use of the NURB
surfaces as representations for radiation compensators.

The typical parametric NURB

representation allows the x, y, and z coordinates to be specified somewhat independently
using only a single knot vector (even for a multi-dimensional curve), with each direction
having an independent control point value. A difficulty with this representation arises,
however, when one wishes to evaluate the resulting NURB curve at intervals which are
constant in any particular coordinate direction. This occurs because the NURB curve
must be evaluated using the parametric variable, u, not an individual x, y, or z position.
Therefore, in order to determine the height of the compensator surface at the center of any
particular beamlet (a known x, y location) a one-dimensional minimization would need to
be performed in each direction to find the correct values of the parametric variables u and
v that yield the desired x and y values. While this is not especially difficult, it is time
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consuming and therefore very undesirable for this application. To circumvent this issue, the
NURB parametrization has been shifted directly to x-y space, meaning the knot vectors are
actually x and y coordinate locations. This forces equal spacing of the control points in the
x-y plane, however, it is shown below that this does not pose any limitations beyond that of
using constant, uniform knot vector spacing and does not hinder representation of the types
of surfaces that are desired in this application.
The extension to two-dimensional surfaces (as opposed to curves described above)
requires adding another knot vector for the second dimension and generation of a matrix
of control points and weights for each valid region of space specified by the knot vectors.
Additionally, the extension of Equation 4.4 for a two-dimensional reduced NURB surface in
x-y space is given as:
i
(CP
CW
θ
(x,
i,
K,
X)
θ
(y,
j,
K,
Y
))
i,j
i,j
j=1
i=1
i
PN x hPN y
(CW
θ
(x,
i,
K,
X)
θ
(y,
j,
K,
Y
))
i,j
j=1
i=1

PN x hPN y
z (x, y) =

(4.5)

where CP and CW are now matrices, X and Y are the knot vectors for the x and y directions,
respectively, and N x and N y refer to the number of control points/weights in the x and y
directions, respectively.
In order to address the concern of whether this NURB surface scheme provides enough
influence and control to specify the types of surfaces expected for a real three-dimensional
radiation compensator, several initial surface studies were performed. First, simple smooth
surfaces were chosen and the NURB control points were placed directly on the desired surface.
Linear, quadratic, and trigonometric surfaces proved to be quite easily captured as evidenced
by the results in Figure 4.5. The error present in the sinusoidal surface shown in Figure 4.5c
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is difficult to visualize directly, therefore a simple average deviation has been computed
(2.6% of the maximum surface height) to verify the high level of surface agreement. It
should be noted that these surfaces all used equal weights for each control point, therefore
further surface agreement could be achieved through adjustment of these values. Modeling
of more complex surfaces containing steps and abrupt changes was then attempted using
the same direct control parameter prescription (i.e. the control points and weights were
adjusted manually in an attempt to match the desired surface shape). Once again such
surfaces were able to be represented to an acceptable degree with the reduced NURB surface
representation. Results for some sample abrupt surfaces are provided in Figures 4.6 - 4.8.
In each of these figures the black mesh represents the prescribed (desired) surface, the red
mesh shows the NURB control points, and the colored surface is the actual resulting NURB
surface (this surface is translucent in order to increase the visibility of the three-dimensional
image). Also, some surfaces are shown as two-dimensional plots, taken at representative
slice(s); in such plots the NURB surface is shown as the solid blue line(s) with all other
colors remaining consistent. It should also be noted that the reduced form of the NURBs
used herein does not provide a direct x-y location for the control points and each is valid
over a small range of the surface corresponding to the knot vector values; the control points
are therefore shown at the center of their respective ranges.
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(a) Bi-Linear

(b) Bi-Quadratic

(c) Sinusoidal

Figure 4.5: Three-Dimensional NURB Surface Testing: Smooth Surfaces

(a) Complete 3D Surface

(b) Center-line 2D Slice

Figure 4.6: Three-Dimensional NURB Surface Testing: Single Abrupt Step
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(a) Complete 3D Surface

(b) Several 2D Slices

Figure 4.7: Three-Dimensional NURB Surface Testing: Abrupt Square Pocket

(a) Complete 3D Surface

(b) Center-line 2D Slice

Figure 4.8: Three-Dimensional NURB Surface Testing: Abrupt Tiered Pocket

Overall these results show that this reduced NURB representation does provide adequate
resolution and control such that the major features of typical radiation compensators can be
well expressed. Additionally, these results demonstrate the important qualities that NURBs
bring to the surface representation, including the elimination of overshoot and reduction of
surface oscillation, as well as greater surface control. The superiority of the NURBs can be
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further visualized by comparing the bi-cubic spline interpolation for an abrupt square pocket
surface (shown previously in Figure 4.3) to that of the NURB surface given in Figure 4.7.
Clearly, the cubic spline is not producing an acceptable surface representation. It could be
argued that adjustment of the control points could produce a more desirable surface match
for the cubic splines; one which does not contain overshoot or undershoot, however the cubic
splines provide no means of analytically controlling the maximum and minimum values (due
to overshoot) so avoidance of this issue cannot be guaranteed in a general sense. Therefore,
the exclusive use of the reduced NURB surface representation is quite justified, but for the
sake of completeness one full treatment planning case is shown in the next chapter to give a
final validation for the exclusion of the cubic spline approach.

4.2

Dose Calculation

Development of computerized dose calculation algorithms is a major reason for the progression of radiation treatment planning to where it is today. This section will provide
on overview of the physics of radiation dose calculations and describe the particular dose
calculation procedure utilized throughout this work.
Radiation dose deposition in tissue is truly a stochastic (random) process.

When

considering a single photon it is impossible to say with certainty where its energy will be
released due to the inherent randomness of atomic arrangement and electron position at
any given instant. However, since a typical radiation treatment involves a huge number
(easily trillions) of photons being delivered to the patient, statistical probabilities become
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nearly exact, making dose calculation a deterministic quantity for any realistic treatment.
This difference in view point for radiation dose deposition has led to development of two
distinct approaches to dose calculation, Monte Carlo methods and deterministic methods.
Monte Carlo methods are a class of techniques where individual particle paths (photons and
necessarily electrons) are simulated using a probabilistic approach (random walks). As the
particles are tracked, collisions with nuclei and electrons, as well as other interactions occur,
and the resulting energy depositions are recorded. Once a statistically significant number
of particles have been traced, the relative energy deposition becomes nearly constant and a
converged solution is achieved (a more detailed description is given by Dupree and Fraley
[38]). Such approaches are regarded as the most accurate as they are modeling the true
physics of the problem in quite a realistic manner. Additionally, experimental results [39, 40]
have shown the excellent accuracy that such methods can obtain and the sentiment that
Monte Carlo calculations are actually more accurate than most experimental measurements
is often observed from those in the field (especially for superficial doses less than 1 cm in
depth). The major downside to Monte Carlo methods is the relatively large computational
times that they require, due to the need to simulate a very large number of particles. This
fact alone is enough to render Monte Carlo methods inapplicable for routine treatment
planning calculations, especially within the context of IMRT inverse planning, since a large
number of competing plans must be evaluated quickly. While much research [41, 42, 43] has
attempted to improve of efficiency of Monte Carlo techniques there is currently no approach
that renders the process efficient enough for routine IMRT inverse planning with common
computational hardware.
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Deterministic radiation dose calculations encompass a much wider range of techniques
including empirical, semi-empirical, and first-principle based approaches. Empirical approaches are the most simplistic and rely heavily upon experimental or Monte Carlo generated data as kernels for the dose calculation. Semi-empirical techniques utilize a combination
of empirical dose kernels and scatter corrections in order to obtain more accurate dose
for inhomogeneous tissue. Pencil beam calculations, such as those described by Plessis
[44], are the most common semi-empirical schemes.

The most accurate and robust of

the deterministic approaches are those derived from first principles. Three-Dimensional
Superposition/Convolution [45] and Collapsed-Cone Convolution [46] calculations are very
commonly used in treatment planning calculations. As expected, the increased accuracy of
each of these techniques comes at the added expense of computational performance. Many
approaches to treatment planning therefore utilize semi-empirical dose calculations during
a majority of the inverse planning process, and limit the use of more accurate methods to
final dose calculations or only at selected intervals throughout the planning process. Such
approaches are commonplace in treatment planning, however some researchers discount this
practice and have attempted to demonstrate the affects of accuracy level during planning on
final plan quality [47, 48]. Scholz, Nill, and Oelfke [48] showed a slight improvement in plan
quality by using superposition compared to pencil beam calculations during planning. Their
work used Monte Carlo simulations to show that the pencil beam solutions were in general no
more than 10% less accurate for highly inhomogeneous tissues such as lungs. However, the
final treatment plans were not 10% lower in quality when planning was completed with pencil
beams versus full Monte Carlo dose calculations. This shows that trends are preserved even
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with lower accuracy dose calculations so that inverse planning is not significantly affected
(except for the case of lung tissue) by the use of lower accuracy models. This observation
helps justify the use of pencil beams throughout the majority of the inverse planning process
for many treatment planning situations.
The main purpose of this research is to present and demonstrate a new concept for
direct delivery parameter optimization with compensators that includes manufacturing considerations during inverse planning, which, as the above discussion has provided, can be
accomplished using a basic dose calculation algorithm.

Therefore, simple pencil beam

calculations are used throughout, with no corrections for heterogeneous tissues. Also, beam
spectral changes and hardening have been included in a fully empirical and qualitative sense
only. While these two simplifications are a major concern for realistic treatment planning,
they do not detract from the overall goal of this research effort. It should also be noted that
incorporation of more accurate and robust dose calculation routines is a relatively minor
endeavor once the basics of the DCPO process have been developed and established herein.
The pencil beam dose calculation process implemented herein is based upon that provided
by Computerized Medical Systems (CMS) for their XiO treatment planning system [32].
The dose calculation is accomplished by summing the dose from each beamlet (pencil beam)
to a set of discrete calculation points (voxels) within the patient. Computing the dose from
a beamlet to a single point requires knowledge of the total energy r eleased per unit mass,
terma, the lateral dose factor, and the relative beamlet strength. The terma is a function of
depth below the patient surface, d, as given by:
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terma(d) = 4 −

a1 exp (−a2 d2 )
+ a4 exp (−a5 d)
a3 + d

(4.6)

where the coefficients a1 − a5 may be tuned specifically for a given beam energy and linear
accelerator. In addition, this work has used these coefficients to incorporate beam hardening,
by allowing each to be a function of the beamlet compensator thickness. It was found that
a linear variation of each coefficient produced a reasonable estimation of the effects of beam
hardening for the range of interest needed herein. The lateral dose factor is computed based
on the beamlet size and shape and the off-axis distance to the point of calculation, r, (i.e.
the perpendicular distance from the beamlet central axis to the current voxel). The beamlet
shape is designed such that the beamlet strength fall-off matches that of the overall beam
and that the sum of the beamlets at any point within the beam is unity. The beamlet profiles
for 5mm spaced beamlets is shown in two-dimensions in Figure 4.9, where the dashed curves
are individual beamlets and the solid red line represents the overall beam. The lateral dose
for such beamlets is given by:

LatDose(r) =





sinh (B H) exp (−B r)

if r > H
(4.7)




1 − cosh (B r) exp (−B H) otherwise
where B is a constant parameter used to control beamlet shape and H is the halfwidth of
the beamlet (radius at which beamlet strength is 50%). The relative beamlet strength, S,
is computed from Equation 4.1 as the ratio I/Io using the thickness at the center of the
beamlet, which is found by evaluating the analytical surface at this location. Finally, the
dose from a beamlet to a single point, p, is computed from the following expression:
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dose(p) = terma (d(p)) LatDose (r(p)) S

(4.8)

where d(p) and r(p) are computed geometrically as previously described.

Figure 4.9: Beamlet Profiles in Two-Dimensions
Despite the simplistic nature of the dose calculation algorithm used for this work, the
quality of the solutions for homogeneous tissue is very good. Figure 4.10 qualitatively
demonstrates the agreement of dose calculation for the pencil beam approach described
above with that of the Philips Pinnacle Treatment Planning System version 8.1. This figure
provides a dose comparison on a cylindrical water phantom (8 cm radius) using 5 coplanar
equally spaced treatment fields. Each field is 10 cm × 10 cm and is blocked on the left half
(x < 0) by a 3 cm thick brass compensator. Dose has been normalized to 100% at the
isocenter and contour lines for 98%, 80%, 60%, 40%, and 20% relative dose are shown for
Pinnacle and this work (DCPO) separately in Sub-Figures 4.10a and 4.10b, and overlaid
in Sub-Figure 4.10c (DCPO dose contours are shown as broken/dashed lines in Sub-Figure
4.10c). The general trends in dose are quite well preserved, which provides the confidence
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needed to ensure that the conclusions drawn in this research would be equally applicable if
a more accurate dose calculation were utilized.

(a) Philips Pinnacle TPS Dose Contours

(b) DCPO Calculated Dose Contours

(c) Isodose Contour Overlay

Figure 4.10: Dose Calculation Comparison: Five Beam Half Blocked 3cm Compensators
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4.3

Inverse Planning and Optimization

In basic terms, intensity modulated radiation therapy is simply an improved means of
planning and delivering highly conformal radiation treatments. What makes IMRT unique
is that the strength of the individual treatment beams is varied in order to achieve this
conformity. The addition of this intra-beam intensity variation greatly increases the difficulties of planning, as the number of variables to control tends to become quite large.
This large number of variables (control parameters) makes traditional planning (i.e. direct
trial-and-error via experience and intuition) almost impossible. Therefore IMRT requires
a computerized planning approach where the modulation parameters are determined via
an intelligent searching process. This is commonly referred to as inverse planning since
the process involves determining treatment parameters necessary for achieving a desired
solution (dose prescription). Traditional inverse planning processes use numerical optimization algorithms to perform the necessary search over the control parameter space. Many
options exist for the numerical optimization, but most choices can be lumped into the two
broad categories of gradient and stochastic methods. Gradient based schemes are typically
regarded as more efficient, however they lack the ability to find global optimums as they are
forced to travel in a purely downhill fashion. Therefore, when the solution space contains
multiple minima, as shown in Figure 4.11, gradient schemes tend to get “stuck” at the lowest
point of whichever hill their initial starting point landed upon. In contrast, stochastic (nongradient based) methods are more likely to find the true global optimum, as they are not
generally forced to maintain only downhill motions; this comes at the expense of increased
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run times however. Regardless of the chosen optimization technique, a major difficulty
with IMRT inverse planning comes from the relatively small correlation that exists between
the strengths of adjacent beamlets. This problem is best described through illustration,
provided by Figure 4.12, which demonstrates the lack of independence of some optimization
parameters (due to fact that multiple beamlets provide dose to same region) and well as the
lack of interdependence (beamlets have no knowledge of the values of their neighbors). The
parametrization of DCPO significantly increases both the interdependence of neighbors which
actually increases the independence amongst the multiple beams. This helps to improve
the efficiency and performance of most optimization schemes, and provides justification for
exploration of schemes which currently perform poorly for beamlet based optimization.

Figure 4.11: Global vs. Local Solution Optimization
Current commercial and academic planning systems use both classes of optimization,
however two methods seem to be particularly common, namely conjugate gradient and simulated annealing. Conjugate gradient is a gradient based approach which is an improvement
over the steepest descent algorithm. Steepest descent involves determining the local optimal
solution by starting from an initial guess and moving in the direction of the highest gradient
to find the next (hopefully better) solution. The process is repeated until the local gradient
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reaches a very small value, thereby indicating the presence of a local minimum/maximum
[36]. Conjugate gradient improves upon this procedure by using information from previous
steps along with the local gradient value to determine a more appropriate search direction
for each step. The popular commercial system XiO by CMS uses a process quite similar to
this conjugate gradient scheme in their implementation [32].

Figure 4.12: Intensity Profile Correlation Sensitivity
Simulated annealing is a non-gradient optimization method which is based upon an
analogy to the manufacturing heat treatment process of annealing. The real annealing
processes involves controlled cycles or stages of heating and cooling a material, starting at
a high temperature. The material is held at various temperatures along a cooling path
in order to promote relaxation of internal stresses by allowing controlled recrystallization
of the atoms. Crystalline structures appear because they are the lowest energy state for
the atoms to arrange themselves in for certain materials, so annealing is a natural energy
minimization process and a good basis for an algorithmic optimization scheme. Simulated
annealing attempts to follow this idea by starting from some initial guess value and testing
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the “energy” (quality of solution) of various small perturbations in the current solution.
Based on the current “temperature” (process control parameter) and the change in energy,
the solution is either accepted or rejected [49]. This is repeated while slowly lowering the
temperature, which adjusts the acceptability criteria for the new trial solutions; as the
temperature decreases it becomes less likely that a higher energy trial solution will be
accepted. This ensures that the process will proceed in a nearly downhill fashion as the
temperature becomes low, thereby facilitating convergence of the algorithm. Generation
of the trial solutions, regardless of temperature or energy, is generally undertaken so that
only small steps are permissible, a process which favors convergence but limits the ability to
“jump” to significantly better solutions. While this technique does not often achieve a true
minimization, it is typically able to reach nearly optimal results even for problems where a
large number of control parameters are present [50].
Another often utilized IMRT optimization approach (more so in the academic setting) is
Genetic Algorithm (GA) optimization. Genetic algorithms were developed in the 1970’s by
John Holland and have since been highly developed, described, and researched by countless
authors. A review of GA details and implementation is provided by Davis [51], but the main
premise is to evolve a set (population) of trial solutions (individuals) through operations
analogous to human reproduction (mutation and crossover) in a manner such that the most
“fit” individuals have the greatest likelihood of reproducing. In the absence of crossover
(i.e. pure mutation) the GA can be shown to be very similar to certain forms of simulated
annealing [52]. Therefore crossover is the primary difference between the operation of these
two techniques and its importance is often noted in the GA literature. Genetic algorithms
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are typically considered an effective means of locating a globally optimal solution, although
the computational burden to reach such a point is often much larger than other techniques,
especially when the number of search parameters is large [53].
As there is no general consensus within the IMRT community as to which optimization scheme is preferable, and also due to the significant parameter correlation sensitivity
changes expected from DCPO, several optimization schemes have been explored for this
work. Specifically, the performance of genetic algorithms, downhill simplex, and several
steepest descent variations have been analyzed. The motivation for choosing each scheme
and a brief description of each is presented in the remainder of this section and then results of
a detailed performance study comparing each approach are provided in the following chapter.
As described, the surface representation used by DCPO increases the optimization
parameter interaction and sensitivity, since unlike a beamlet based approach, each control
point affects a region of the surface, as opposed to an isolated location. This increase
in parameter inter-dependence (or abstraction) has generally been shown to improve the
performance of genetic algorithm optimization [54]. Therefore, GAs should be more likely
to perform well for DCPO than for traditional beamlet strength optimization. Additionally,
due to the often reported similarity between GA and simulated annealing performance [52]
and this author’s familiarity with genetic algorithms [33, 34, 35], they have been chosen
for exploration herein, exclusive of simulated annealing. Several gradient based optimizers
have also been implemented and tested for this work. The motivation for exploring these
techniques is the vast body of research and literature that demonstrates the exceptional
convergence rates of these approaches (see [36, 55, 56] for example). Due to these fast

61

convergence rates, acceptable solutions can often be achieved in only a handful of iterations.
Therefore, several variations on the classic steepest descent algorithm have been investigated,
including conjugate gradient and variable metric optimization. The downside of typical
gradient based techniques is unfortunately the computation of the gradient itself. Therefore,
gradient approximation techniques, such as Broyden’s method, have also been utilized herein.
The non-linear downhill simplex method of Nelder and Mead [57] is a gradient-like approach,
where direct computation of the gradient is avoided, and instead a simplex (n+1 dimensional
surface) is allowed to “crawl” along the solution space in a downhill fashion. This technique
has been shown to effectively determine local minima with no need to explicitly compute the
gradient [36]. With the motivations established, the details of each approach are addressed
after a description of the objective function calculation.
Regardless of the type of optimization performed, a means of comparing the quality
of each trial solution is necessary. This is accomplished via a fitness function that specifies
the relationship between the input parameters and the quality of the solution. For the case
of IMRT treatment planning with DCPO the input parameters are the following (for each
treatment beam): 1) overall beam weight, 2) matrix of control point heights, and 3) matrix
of control point weights. These input parameters are sent to the NURB surface calculation
routines described in Section 4.1, which facilitates calculation of the individual beamlet
heights. The beamlet heights are then sent to the dose calculation module which computes
the resulting dose inside the discretized patient geometry. Finally, the resulting dose at each
point is compared with the prescription and the following expression is used to determine a
single value for the objective (fitness) function, φ:
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φ=

N
X
j=1

)
nj
X


βj
(Di − Dpi )2

(

(4.9)

i=1

where N is the number of important anatomical structures (PTVs and OARs), nj is the
number of discrete points (voxels) within a particular structure, βj is the importance weight
for a particular structure, Di is the computed dose at voxel i, and Dpi is the prescribed
dose at the same point. It should be noted that this prescribed dose may be a range rather
than a single value in which case Dpi takes on the maximum or minimum allowable value,
as appropriate. Additionally, in order to make the OAR doses as small as possible and the
tumor as homogeneous as possible, a linear contribution is added to the objective function
even when the dose, Di , falls within the prescribed range. This new objective function follows
that of CMS’s XiO planning system [32] and is illustrated for a sample PTV and OAR in
Figure 4.13. Additionally, in order to facilitate the use of gradient approximation techniques,
such as Broyden’s method [36], the form of Equation 4.10 has also been modified, providing
a new objective function in the form:
φ=


PN Pnj  2
i=1 fj (xi )
j=1
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Figure 4.13: Optimization Fitness Functions (PTV and OAR)
The focus of many classic papers on genetic algorithms has been achieving the property
of robustness, so that performance is maintained over a wide range of problem types.
This is often a worthwhile goal, as the majority of optimization problems generally require
only one solution or set of solutions; especially for standard design optimization problems
where only one final design is needed. However, it is quite intuitive that specialization
can allow performance improvements for a particular class of problems, at the expense of
robustness, and many authors (see [51, 58] for example) have corroborated this idea. Such
specialization is very important herein as IMRT treatment planning falls into the rare class
of problems where numerous optimization runs are needed, since every patient requires an
optimization for a highly similar situation; thus the genetic algorithm developed for this
work has been tailored to perform specifically for radiation planning problems through a
rigorous development and tuning process. This tuning process has led to a final form of
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the GA in which real number representation is utilized, along with linear fitness scaling,
single-point cross-over, and a diploid style chromosome without dominance (phenotypes
are computed as the average of the gene value from each chromosome). A steady-state
reproduction style is used in which a small number of children (≈ 10% of the population
size) are generated and replace the worst individuals in the population. This ensures that
the best individuals are maintained (elitism) and eases the implementation of disallowing
duplicate individuals. Both sexual and asexual forms of reproduction have been utilized.
Sexual reproduction involves each parent sending one complete chromosome to the new
child. The value of this chromosome is determined in one of three ways: directly send one of
the parent chromosomes, crossover the two chromosomes from a parent and send one of the
resulting new chromosomes, or directly send the parent phenotype (average) values. Asexual
reproduction is accomplished via three mutation operators: traditional random mutation
which acts on individual genes, “single creep” mutation which increments a single gene by
a small amount, and “multi-creep” mutation which increments the entire chromosome in
a problem specific manner. The mutation rates for each operator are adjusted in a linear
fashion as the solution progresses in order to achieve a good balance between global and
local searching. Random mutations are slowed and creep is increased throughout each run.
Steepest descent is a more straight-forward technique and is the most fundamentally
simple gradient based optimization approach, as described above. Each additional gradient
technique used in this work is a direct modification to this basic algorithm, therefore, the
exact approach to steepest descent taken herein will now be explained in more detail. The
process starts with some initial trial solution that can be random, based on prior solution
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knowledge, or constructed using geometric rules. The gradient is then calculated numerically
using a finite differencing approximation. The gradient of a scalar dependent variable, φ, in
n-dimensional space is given as:

∇φ =

n 
X
∂φ
i=1

∂xi


−
→
e xi

(4.11)

where −
e→
xi is a unit vector in the xi direction. The necessary partial derivatives are approximated using the following one-sided finite difference expression:
φ (x + αj (r, i) 4x) − φ (x)
∂φ
≈
∂xi
αj (r, i) 4x

(4.12)

where 4x is some small preset perturbation value [Θ (10−3 )], i is the current coordinate
direction for differentiation, r is a uniformly distributed random number ranging from zero
to one, and:





1
if ((r ≤ 0.5) & (i = j))





αj (r, i) = −1 if ((r > 0.5) & (i = j))








0
otherwise

(4.13)

This form accomplishes a forward difference approximation for r ≤ 0.5 and a backward
difference otherwise, ensuring that the calculation of derivatives does not bias the solution
process (central differencing is avoided as this would double the workload of computing the
gradient vector). For the case of IMRT treatment planning, φ, is directly the fitness value
obtained from the formulation given by Equation 4.10 and xi corresponds to each of the input
parameters. Once the gradient is known, steepest descent utilizes the following equation to
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move the trial solution to the local minimum in the direction opposing the gradient:
(k+1)

xi

(k)

= xi − L(k) (∇φ)(k)

(4.14)

where L is determined via one-dimensional minimization along the gradient direction (an
inverse parabolic interpolation approach [36] has been utilized herein). Additionally, a
gradient approximation scheme (Broyden’s method [59]) has been implemented to eliminate
the need to compute the full gradient (via finite differencing) at each iteration (the full
gradient is computed via finite differencing only for the first iteration and at some preset
iteration counts). For Broyden’s method the gradient is approximated using the following
two relations:
(∇φ)(k) = 2 J T f

(k)

(4.15)

where

J

(k)

≈J

(k−1)

 (k−1) (k)

 (k)
T
J
x − x(k−1) − f (k) − f (k−1)
x − x(k−1)
−
(x(k) − x(k−1) ) · (x(k) − x(k−1) )

(4.16)

and the initial Jacobian matrix, J, is computed using finite differencing (analogous to that
shown above) such that:

Jij =

∂fj (xi )
f (x + αj (r, i) 4x) − f (x)
≈
∂xi
αj (r, i) 4x

(4.17)

Despite the intuitive nature of steepest descent it is actually quite inefficient, because
the current iteration utilizes only the local gradient information and takes no account of prior
search directions. Also, as the previous trial solution was found by minimizing along the
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gradient direction, the next step is guaranteed to have the gradient direction perpendicular to
the previous. Conjugate gradient was developed to alleviate this concern by ensuring the new
search direction is conjugate to the previous directions as much as possible. This generally
results in a more efficient and less oscillative iteration process compared to steepest descent
[36]. A similar scheme, the variable metric approach, is often shown to provide slightly more
stability and efficiency in the selection of search directions [56]. Both these processes have
therefore been implemented and tested herein and no consistent benefit was found from either
approach, therefore only conjugate gradient has been considered for further investigation.
The non-linear downhill simplex method is based upon the geometric entity known as
a simplex, which is an n-dimensional polytope, consisting of n+1 points in n-dimensional
space. In two-dimensions a simplex is a triangle, and the downhill simplex optimization
process is easily visualized as a triangle being flipped, extended (stretched), and contracted
(shrunk) in an effort to “crawl” down the surface to reach the minimum point. This crawling
is accomplished by attempting to “flip” the simplex with the worst vertex moving along the
line connecting it with the centroid. The resulting new vertex is then accepted or rejected
based on a set of rules regarding its relationship with the other vertices. If acceptable the
search may be extended along this direction in an attempt to move further down the hill.
If the process is rejected, the simplex can contract or shrink toward the best vertex in an
attempt to squeeze into small local minima. The process generally converges more slowly
than gradient based schemes, but the benefit of not requiring calculation of the gradient
makes the overall process more computational efficient in some situations [36]. The standard
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form of the non-linear downhill simplex method presented by Nelder and Mead [57] and
reviewed in [36] has been implemented herein.
This section has provided the details of each numerical optimization approach selected
for analyzation herein. The motivation for each selection was also presented and the following
chapter will continue with completion of the full performance analysis for each of the three
techniques.

4.4

Manufacturing

This work proposes to improve the delivery of IMRT by incorporating the specific constraints
of the milling process into the inverse planning optimization. Incorporating machining
considerations into the planning process is unique in that it closes the design loop and allows
for greater consistency between actual delivered radiation dose and planned radiation dose
compared to current methods. This is made possible because the DCPO approach developed
herein is a direct delivery parameter optimization approach, whereby the actual compensator
shapes are known during inverse planning. During inverse planning most treatment planning
systems, both academic and commercial, consider only ideal fluence modulation (DAO
approaches being the exception) and do not consider whether a compensator is capable
of being manufactured to achieve the prescribed modulation (or if the plan is deliverable for
MLC based techniques as MLCs also have some delivery limitations). Furthermore, most
current techniques generally require a smoothing algorithm to ensure that the compensator
surface is not jagged or stair cased. This smoothing changes the compensator shape and
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with it the delivered dose. Thus smoothing necessitates an additional dose calculation step
to ensure that the delivered dose has not been excessively degraded by the smoothing process.
It is also not uncommon that even after smoothing, the compensator design produced by a
treatment planning software is simply unable to be manufactured to the desired specifications
(generally because the smoothing algorithms are not based on a particular manufacturing
process). These issues with the current design process are a large contributor to discrepancies
between the optimal planned dose, the calculated deliverable dose, and the actual delivered
dose. Ensuring that the DCPO based planning system uses only 100% manufacturable
compensator designs effectively closes the compensator design loop and helps decrease these
differences between planned and delivered radiation doses.
This discussion has shown that two major benefits arise from the incorporation of
manufacturing into the planning loop: (1) complete agreement between each trial plan dose
and deliverable dose (which also removes the need for secondary deliverable dose calculations)
and (2) increased agreement between final (optimal) planned and actually delivered radiation
dose. The effects of manufacturing inclusion on the planning process can seen by comparing
the flow chart in Figure 4.14 to that of the standard inverse planning process chart given
previously in Figure 3.9 (see page 32). This figure shows the simplification offered by this
work through elimination of the secondary loop in the current process (Figure 3.9) by moving
this step into the main design loop with the DCPO process (Figure 4.14).
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Figure 4.14: New DCPO Compensator Design and Manufacturing Processes
Consideration of compensator machining constraints in this work is undertaken in an
indirect fashion. An indirect approach is needed because performing a complete milling
simulation on the large number of trial solutions that must be generated and tested during
the inverse planning process would be prohibitive. Manufacturability is therefore addressed
by imposing limitations on the control parameters used by the compensator surface representation scheme. Appropriate limitations are determined specifically for this work by
utilizing milling surface limitations as well as through the use of milling simulation software
from compensator manufacturing firm .decimal, Inc. The control parameter limitations are
found through an analysis of various compensator designs that contain many features which
commonly create difficulties for the milling process, such as steep walls and deep valleys.
Deep valleys can lead to under-cutting, see the shaded blue region in Figure 4.15, while steep
walls can necessitate the use of five-axis milling (when wall steepness exceeds the slope of the
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tapered milling tools). The simulation results and tooling constraints are used to determine
bounds for the control parameters such as minimum control point spacing and allowable
control point weight ratios. These bounds are used within the optimization portion of the
inverse treatment planning process to efficiently enforce manufacturing constraints during
treatment planning. The results of this machining study, as well as a thorough discussion of
the implications on surface control, are provided in the following chapter.

Figure 4.15: Milling Tool Limitation Example
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4.5

Summary of DCPO

As described above, the process of Direct Compensator Profile Optimization involves several
novel ideas and contributions to the field of compensator intensity modulated radiation therapy, including being the first direct delivery parameter optimization scheme for compensator
based IMRT treatment planning. The above descriptions have been necessarily broken up,
so that the details of each development could be sufficiently explained. This section therefore
provides a brief yet complete description of DCPO so that synthesis of the various processes
is achieved. A basic flow chart describing the DCPO approach is therefore shown in Figure
4.16.
In summary, DCPO utilizes an analytical surface representation scheme to describe the
compensator surfaces (thicknesses) during inverse planning. The analytical surface allows
for calculation of individual beamlet strengths. At this point, the process directly follows
traditional planning, including the use of standard pencil beam dose calculation algorithms
(with appropriate beam hardening corrections) and an iteration loop which can be completed
using one of several different optimization schemes. Figure 4.16 highlights the similarity
between the DCPO process and standard approach as far as the basic treatment planning
algorithm is concerned, with the only high-level difference being the solution representation
used in the first two steps. This similarity is quite beneficial as it will allow incorporation of
DCPO into existing planning systems with only isolated modifications and additions by later
investigators. However, what is difficult in such a high-level description is understanding
the fundamental benefits that DCPO offers and provides at each of the stages (boxes)
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indicated in Figure 4.16. In the first stage, DCPO provides a reduction in the number
of parameters needed to specify the fluence field. The second stage is new to DCPO as
traditional approaches optimize the beamlet strengths themselves. Stage three may be
performed identically to standard schemes, however, since DCPO provides physical delivery
device parameters (i.e. compensator thicknesses) at this time, there is no penalty or added
difficulty for including beam spectral changes and compensator-induced scatter at this point
in the planning dose calculations. The fourth and fifth stages are no different from existing
approaches as the fitness and quality of a treatment plan are judged solely on the patient
dose distribution. The final stage again appears to match existing techniques, however with
DCPO there is no need for a final dose calculation or quality assurance feedback loop (due
to smoothing) as these issues are directly handled in the trial solution representation.

Figure 4.16: Process Flow Chart for DCPO
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CHAPTER 5
RESEARCH DEVELOPMENTS

The process of Direct Compensator Profile Optimization has been explained and the potential benefits thoroughly described. This chapter therefore focuses on the procedures
undertaken to test this new methodology, verify its performance, and determine the most
appropriate and effective schemes to utilize for each particular stage of DCPO. This procedure began with a preliminary implementation of the complete DCPO process in a simplified
two-dimensional sense such that the fundamentals of the approach could be tested and
verified. As a goal of DCPO is to be applicable to realistic patient configurations, complete
development and implementation of each of the schemes described above was then performed.
Testing and verification was completed in various stages throughout the process in order to
ensure each new development was performing as expected. This chapter presents results in
a manner consistent with these verification procedures, thereby illustrating the development
process and showing the rigor used to ensure proper functioning and performance of each
of the DCPO routines. This thorough testing was used to assess the performance, ascertain
any areas of deficiency, and aid in the refinement of the solution approaches for each part
of the DCPO process. This testing also addressed the issue of manufacturing constraint
determination and several example cases are shown which provide a means for quantification
of the surface control parameters necessary to ensure complete surface machinability.
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5.1

Initial Process Verification

The initial process verification began with implementation of cubic spline surfaces for compensator representation, a basic dose calculation module, and genetic algorithm optimization
routine. The goal of this initial stage was only to prove the soundness of the DCPO concept
(efficiency or accuracy were not addressed at this point), therefore the choice of cubic splines
and genetic algorithms was made purely for convenience as the author has considerable
experience with these procedures [35, 34, 60, 33]. Two simulated patient test cases were
completed so that initial verifications could be made before moving on to more rigorous
developments and testing. The details of these two test cases are presented in the remainder
of this section.

5.1.1

Verification Case #1

The first test case consists of a simple circular patient skin surface with an off-center target
volume (PTV) and two symmetrically placed organs-at-risk (OARs). The geometry of this
simulated patient is shown in Figure 5.1. The optimization was carried out by setting the
cost (objective) function based on maintaining the PTV relative dose range between 100%94%, while minimizing the dose to the OARs and rest-of-body (note that the dose fields
here have been normalized to produce a maximum of 100%, therefore the target PTV dose
is 97% with 100% being the maximum allowable value). Results were obtained using 7 and
9 equally spaced treatment beams. The resulting relative dose fields for each case are shown
in Figure 5.2, as well as the resulting compensator shapes for the nine beam case in Figure
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5.3. A Dose Volume Histogram (DVH) is then provided in Figure 5.4 which allows for a
more direct quantitative analysis of the resulting treatment plan.

Figure 5.1: Verification Test Case #1: Simulated Patient Geometry

(a) Seven Beams

(b) Nine Beams

Figure 5.2: Verification Test Case #1: Dose Field Results
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Figure 5.3: Verification Test Case #1: Compensator Results

Figure 5.4: Verification Test Case #1: Dose Volume Histogram

5.1.2

Verification Case #2

The second example case consists of a “C” shaped target volume adjacent to a small round
organ-at-risk, to simulate a more complex spinal region treatment. The simulated patient
geometry is shown in Figure 5.5 and the resulting dose field for nine equally spaced treatment
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beams can be seen in Figure 5.6. The resulting compensator shapes for each beam are shown
in Figure 5.7. Again a relative dose of 100%-94% was used for the PTV and minimization of
dose was used for the OAR and rest-of-body. Figure 5.8 shows the DVH plot, showing the
reasonable quality of the DCPO planned solution.

Figure 5.5: Verification Test Case #2: Simulated Patient Geometry

Figure 5.6: Verification Test Case #2: Dose Field Results
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Figure 5.7: Verification Test Case #2: Compensator Results

Figure 5.8: Verification Test Case #2: Dose Volume Histogram
After completion of these results it was determined that inclusion of an overall beam
weight factor was necessary within the optimization scheme as an added control parameter.
An inspection of Figures 5.3 & 5.7 reveals that most of the compensators do not provide
modulation over the entire range of interest; in other words single beams do not span from
zero thickness to full thickness. This lack of minimum thickness region on most of the beams
points to the fact that the compensator is providing the overall beam weighting by limiting
the minimum thickness of the surfaces. This is undesirable as it limits the useful modulation
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range of the devices. Therefore, the remainder of this work has included an overall beam
weight factor for each individual beam (in addition to the standard surface control parameters
described previously), which specifies a temporal weighting and was found to eliminate this
concern and significantly improve the resulting treatment plans.
Although, these cases are reasonably simplistic in nature they have proven that the
DCPO process is sound and that the parametrization scheme does not prevent the ability to
produce reasonable treatment plans. It should be understood that these results are provided
only to demonstrate the preliminary verification of the DCPO process. Therefore, the quality
of these plans should not be overly concerning at this time (as each of the competing processes
are further developed below it will be shown that much higher quality results can be achieved
with DCPO). Overall, this initial effort provided motivation for continuing development
into DCPO and gave insight into the areas which needed extra attention as the research
moved forward. The next stage of this research required the complete development and
implementation of each of the various schemes described in the previous chapter so that
efficiency and accuracy can be addressed within the DCPO process.

5.2

Manufacturing Considerations

The determination of manufacturing constraints is a key aspect and major innovation of this
work. As such, a thorough performance study has been completed in order to address this
area. As described previously, the two major concerns when compensators are manufactured
using a milling procedure are under-cutting and surface slope (wall steepness). In order to
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prevent problems in these areas from arising in this work, the NURB surface parameters will
be controlled through a bounding and limiting scheme. Before this scheme was developed
and the bounds/limits quantified it was important to ascertain the typical values which limit
the surface machinability. Typical milling limitations were obtained from .decimal, Inc. as
they are a leading manufacturer of solid metal compensators. Their standard manufacturing
process utilizes three-axis milling with a ball nose (rounded) minimum tool tip diameter of
1/800

( 0.3175 cm ). Additionally, as typical compensators contain quite deep valleys, this tool

generally has a tapered shaft to increase its strength and stiffness (such a tool is shown in
Figure 5.9). As this is the tool used for finishing operations, it is the smallest tool used and
is the main limitation within the milling process. The dimensions of this tool, along with a
small safety factor, directly provide the necessary milling constraints. Table 5.1 quantifies
the values which are typically employed in manufacturing facilities. In addition to these
milling constraints, typical linear accelerators have limitations on the sizes of compensators
which can be placed into the treatment head tray. These limitations are also included in
Table 5.1.

Figure 5.9: Typical Machine Tool Used for Final Milling

Table 5.1: Milling Constraints and Limitations
Minimum Radius Taper Maximum Height Minimum Height
Tool

0.159 cm

2o

10 cm

–

Surface

0.159 cm

3o

8 cm

3 mm
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Once the appropriate machining limitations had been found it became necessary to
determine the corresponding NURB control parameters that would prevent violation of the
limitations (only NURB surfaces were considered during this study as the inapplicability of
cubic splines to DCPO has already been described). The most obvious and simple means of
satisfying the tray size limitations is to limit the control point values (z-direction heights)
between the maximum and minimum allowable thickness values. This is possible due to the
bounding property of the NURB surfaces, which means that actual surface thicknesses will
always remain within the bounds of the control point range.
The remaining two constraints are a bit more challenging to uphold and a two fold
approach is used to address both constraints simultaneously, by limiting the x and y spacing
of the control points as well as the control weight ratios.

An initial estimate on the

minimum allowable control point spacing, with regards to surface steepness only, was found
by assuming that the surface is locally linear and that it passes directly through each control
point. This means for the given maximum and minimum surface heights as well as the
surface angle limitation, a simple trigonometric calculation provides a value of 0.419 cm as the
absolute lowest allowable horizontal spacing. However, this estimate is quite rudimentary and
due to the complex relations between the NURB surface and the control point heights and
weights, the surfaces can actually be steeper than this elementary linear estimate provides.
A simple half blocked compensator (similar to that shown in Figure 4.6) can be used to
demonstrate the effects of control point spacing on the maximum surface slope. Figure 5.10
shows a slice of the NURB surfaces resulting from four different horizontal spacing values.
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Analysis of these results shows that the surface slope threshold is broken at a spacing of
approximately 0.588 cm not 0.419 cm as predicted by a purely linear assumption. This half
blocked field is an important test case as it produces the maximum possible change in height
over the minimum possible distance. Therefore, it was decided that a value of 0.600 cm be
used as the minimum allowable control point spacing for surface steepness concerns.

Figure 5.10: Control Point Spacing Effects on Surface Steepness
This process of limiting the x-y control point spacing affects not only the steepness
of the surface, but also the size of the internal valleys that can lead to under-cutting of
the compensator surface (see Figure 4.15 for a description of under-cutting). It should be
recognized that the control point spacing alone could be used to address both steepness and
under-cutting concerns, however initial testing proved that such a simplistic approach was
far too limiting to the overall resolution of the surface. Therefore, this study also determined
guidelines regarding the weights of the NURB control points which allowed for closer spacing
while still limiting the slopes and valleys in the desired fashion.
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This discussion has shown that the two major goals of this study are to find: (1)
the minimum allowable control point spacing to ensure surface slopes are not beyond the
threshold and (2) the allowable range of weight ratios and control point heights that ensure
valley sizes prevent the possibility of under-cutting. The half blocked case shown above has
already provided an appropriate value to satisfy the first of these goals. The second goal is a
bit more complex and the first few example problems below have been designed to aid in this
determination. The remaining examples demonstrate the performance of the constraining
process. This effectively proves that every compensator produced by the complete DCPO
process is fully machinable, thereby satisfying one of the major objectives of this research.
The first example considered is the most obvious case which can potentially create an
under-cutting situation, a single deep valley (pocket). The simplest version involves having
just one control point at the minimum allowable thickness while all others remain at the
maximum. The valleys resulting from several different control point spacing and weight
combinations are shown in Figures 5.11 - 5.12. The first of these figures shows the effects
of control point spacing for uniform weights. These results show that for the range of
control point spacing expected in this work the NURBs are unable to violate the machining
constraints when equal weighting is utilized. However, Figure 5.12 reveals that non-equal
weighting can have a significant impact on the resulting NURB surfaces. This figure displays
the results at a fixed control point spacing (0.625 cm) for various weight ratios. An important
observation is that the weighting is able to increase the depth of the valley and thus the
surface steepness is increased, however, the radius of the valley trough is actually increased
which improves the manufacturability. This example proves that for the minimum expected
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spacing a weight ratio of up to 20:1 may be used without violating any of the pertinent
machining constraints. Also shown in each of these figures (as a black line) is a three degree
sloped pocket with a bottom diameter of 0.3175 cm which represents the minimum possible
pocket that can be created using the described milling procedure.

Figure 5.11: Control Point Spacing Effects on Surface Steepness and Valley Radius

Figure 5.12: Control Point Weight Effects on Surface Steepness and Valley Radius
The above examples have provided useful initial values and ranges for the NURBs control
parameters, however more rigorous testing is needed before confidence can be established
in these results. Therefore, several more complex surfaces have been analyzed to provide
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such testing. Figure 5.13 shows the results of a doubly peaked compensator shape. Such
a surface has steep grades which nearly approach the maximum allowable limits, as well as
deep internal radii which also approach the minimum allowable size. The blue curve shows
the surface, while the solid green shapes represent the milling cutting tool for comparison
purposes. Figure 5.13b shows that the center section has just reached the tool limitation,
which shows that a weight ratio of 20:1 is again satisfactory for the control point heights
and spacings utilized above. Figure 5.14 shows a slightly wider channel, which contains two
control points located at the minimum allowable height. It was found that this scenario
actually is able to produce a more abrupt pocket than is the case of a single centrally
located control point. While surface steepness concerns are still unable to be violated for
this arrangement, it was found that as the weight ratio between the lower nodes and upper
nodes was reduced, the radius of the internal valley decreased significantly. Comparing
several weight ratios revealed that a 1:5 ratio (lower node weights smaller than upper) was
about the threshold where undercutting become evident. Therefore, it was concluded that
the weight ratio limitations will need to check the relative heights between nodes and always
compute the adjacent node weight ratio so that the higher node (greater thickness) is in
the denominator of the ratio so that consistent bounding is achieved. Several additional
configurations were also developed and tested, but none proved as limiting as those presented
herein.
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(a) Entire Central Axis Slice

(b) Expanded Central Valley View

Figure 5.13: Control Weight Effects on Manufacturability (Double Peaked Surface)

(a) Entire Central Axis Slice

(b) Expanded Valley View

Figure 5.14: Control Weight Effects on Manufacturability (Two-Point Valley)
From these results it can be observed that manufacturing limitations can successfully
be indirectly included within the treatment planning process by constraining the NURBs
control parameters. These results have also shown that this inclusion can be accomplished
by simply imposing both upper and lower bounds on the NURB control point heights and
weights, as well as limiting the minimum horizontal control point spacing. Additionally,
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this study has exposed the fact that these bounds and limitations are not prohibitive to the
treatment planning process and in fact these bounds are actually beyond the values expected
for routine clinical planning (typical beamlet based planning systems limit the resolution to
0.50 cm − 1.00 cm so that in order to achieve a reasonable parameter reduction with DCPO,
spacing should be limited near 0.80 cm − 1.25 cm). Table 5.2 gives the final values which are
used for the remainder of this work regarding limiting the NURBs control parameters.
Table 5.2: Final NURBs Control Values for Milling Constraint
Horizontal Spacing Control Heights Control Weights

Weight Ratio

Minimum

0.625 cm

0.3 cm

0.05

1:5

Maximum

2.0 cm

8 cm

1.0

20:1

As further evidence of the manufacturability of the compensators designed with this
approach, complete milling simulation has been completed on several compensator surfaces.
This simulation provides complete specification of the milling tool path as well as a quantification of the error between the prescribed and milled surface. Analysis of the results for
simulations of the stepped, pocketed, and tiered surfaces showed that the maximum undercutting distance was found to be less than 0.1mm (0.0039”), over-cutting was negligible
(below 0.01mm), and the minimum surface angle (steepness) was 4.2o from vertical, within
the allowable minimum of 3o . These results indicate the success of three-axis milling for these
parts and give confidence that compensators developed using the DCPO process are nearly
100% machinable. Figures 5.10 & 5.16 show sample images from these milling simulations
complete with tool path lines for small portions of the roughing and finishing cuts.
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(a) Roughing Tool Paths

(b) Finishing Tool Paths

Figure 5.15: Sample Milling Simulation Results

(a) Roughing Tool Paths

(b) Finishing Tool Paths

Figure 5.16: Sample Milling Simulation Results
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5.3

Optimization (Inverse Planning) Analysis

At this stage of the project initial testing has verified that both dose calculation and
surface representation routines were functioning as expected. Additionally, manufacturing
limitations had been fully quantified and the DCPO process was theoretically ready for full
testing. However, since the optimization process is the main determinant of overall efficiency
and plan quality, each competing optimization scheme required intense performance testing
before an appropriate decision could be made. Two distinct efforts were carried out in this
regard with the aim of isolating two key aspects of the inverse planning processes: large
parameter count performance and effects of high parameter interdependence (sensitivity).
The performance of each optimization routine for large parameter counts is important
since typical three-dimensional treatment plans will require several hundred independent
optimization parameters even with the reduction offered by DCPO (a single 10 cm × 10 cm
field would require roughly 100−200 parameters using 1 cm control point spacing for DCPO;
in contrast using a standard beamlet size of 0.5 cm would require 400 parameters for a
traditional planning approach). Large parameter count optimization was addressed in an
efficient manner by directly optimizing to a prescribed compensator shape (momentarily
removing the patient and dose calculation concerns). Performance and tuning of each
optimization scheme was carried out for several such test cases. Next, the effects of increased parameter interdependence due to the DCPO parametrization were analyzed by
examining the performance of each optimization scheme on several two-dimensional test
cases. Two-dimensional test cases are used for several reasons: (1) the reduced problem size
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allows optimization to be carried out for longer intervals, (2) the comparison of results and
plans is more straight forward, and (3) three-dimensional analysis is nearly equivalent to
repeated two-dimensional analysis. Also, the optimization routines actually do not require
any modification for the transition to three-dimensions, as their use is dependent solely upon
an input “string” of values representing the NURB or cubic spline surface control parameters
and the resulting objective function. Furthermore, the parameter interaction and sensitivity
with respect to one another is expected to be on the same order for both two- and threedimensional surfaces.

5.3.1

Large Parameter Count Optimization

Large parameter counts are often very difficult for certain types of optimization schemes to
handle efficiently, therefore this issue received first priority. These tests involved attempting
to match a preset surface shape, by optimizing the NURB surface control parameters. A simple quadratic objective function was used for each optimization routine, essentially creating
a Least-Squares surface fitting routine. Testing began with simple smooth surfaces such as
linear and quadratic functions and then progressed to more complex, realistic compensator
shapes. Each of the optimization schemes performed adequately for the simple surface
tests and no major difficulties were encountered, although genetic algorithm performance
was somewhat less compared to simplex and gradient based approaches. This performance
difference became much greater as surface complexity increased. Results for some exemplary
cases for each optimization approach are provided below, along with a discussion of the
general observations seen during completion of the various test cases.
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Specifically, results for two test cases are presented. Test case (a) consists of a single
12 cm × 12 cm field with a stepped pocket compensator that is 1 cm thick when |x| <
4 and

|y| < 3, and 6 cm thick otherwise, with the origin placed at central axis (this

ideal surface is shown in black in the background of each of the results below). The NURB
surface is optimized using a 10 × 10 field of control points and weights and the objective
function (surface agreement) is computed at 0.5 cm spaced locations along the surface. Test
case (b) consists of a single 12 cm × 12 cm field with a radially symmetric island pocket
compensator that has a thickness of 3 cm for |r| ≤ 1, 0 cm for 1 < |r| ≤ 3, and 8 cm
otherwise, with the origin placed at the central axis (again this ideal surface is shown in
black in the background of each of the results below). The NURB surface is optimized using
an 11 × 11 field of control points and weights and the objective function (surface agreement)
is again computed at 0.5 cm spaced locations along the surface.
Initial three-dimensional, large parameter count testing quickly proved that even with
the parameter reductions gained by DCPO, the genetic algorithm optimization schemes
did not perform very well. Performance for the GA approach was mediocre, with poor
surface agreement and surface oscillations often still persisting even after excessively long
optimization runs (millions of trial solutions). It was found that despite the parametrization
provided by the DCPO approach, 100 − 200 parameters are still needed in order to provide
the resolution needed to describe a single useful compensator. This number of optimization parameters proved too great for direct application of standard genetic algorithms as
demonstrated by the extremely slow convergence after the initial rapid improvements. This
problem is supported by this author’s prior research [33, 35] and is also well known and
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supported in the field [61, 62]. Results for the two surface shapes described above are given
in Figure 5.17 for genetic algorithm optimization.

(a) Pocket

(b) Pocket with Island

Figure 5.17: Genetic Algorithm Optimization Testing: Direct Surface Optimization
The downhill simplex and gradient-based optimization algorithms were found to be quite
similar in behavior and both were effective at locating local solution minima. Initial testing
of these approaches found that high quality solutions could be obtained much more quickly
than with the genetic algorithms and that each technique seemed to converge to the same (or
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nearly the same) solution from several different initial guess values (constant thickness and
completely random initial guesses were both tested). Figure 5.18 shows the sample simplex
solutions while Figure 5.19 shows the same examples for the conjugate gradient approach
(although several gradient-based optimization routines were tested the final results of each
were quite similar with efficiency being the only variable; therefore as conjugate gradient
was found to be the most efficient only results for this approach are presented).

(a) Pocket

(b) Pocket with Island

Figure 5.18: Simplex Optimization Testing: Direct Surface Optimization
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(a) Pocket

(b) Pocket with Island

Figure 5.19: Gradient Optimization Testing: Direct Surface Optimization
The similarities between the downhill simplex and gradient optimization schemes for
these cases are quite impressive. As these initial trials involved optimizing directly to a
prescribed surface shape, it is likely that only one family of optimal solutions exists (family
is used as it is the NURBs weight ratios and not the weights themselves that dictate
the surface shape, therefore multiple (identical) solutions can exist as long as the weight
ratios are equivalent). The existence of such a small set of optimal solutions leads to the
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notion that the search space has only several nearly equivalent local minima (or a single,
flat global minima). This is evidenced by the repeatability of the gradient and simplex
solutions, since numerous initial guess configurations converged to nearly the same final
results. A quantitative comparison of the simplex and conjugate gradient results shows that
the maximum difference in surface height at any point is 10%, however this is a vertical
difference which occurs only on the steep walls of the pocket; therefore actual surfaceto-surface distance (perpendicular distance) is considerably less and the average surface
difference is only 1.5%. An effective qualitative comparison of the solution agreement is
achieved by overlaying plots of two-dimensional surface slices, which has been done in Figure
5.20. This figure shows that the gradient solution (red lines) is slightly better than the
simplex (blue lines) as it is closer to the desired surface (black lines) over a majority of each
slice (solid lines depict a slice at the center-line, while the dashed line slices are midway
between the center and field edge; the field is not symmetric and the x and y directions are
shown on the left and right respectively).

Figure 5.20: Conjugate Gradient vs. Downhill Simplex Direct Surface Optimization
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Despite the similarities in solution quality, the efficiency of the techniques was markedly
different. The conjugate gradient method consistently converged in fewer iterations and
required fewer total function evaluations compared to downhill simplex. This behavior is
illustrated by comparison of the curves in Figure 5.21, which shows the objective value as a
function of the number of function evaluations for each optimization scheme. The conjugate
gradient method converged most rapidly for these, and most all, example problems that
were tested, requiring only a small quantity of iterations to converge (20 − 50). Even with
this rapid convergence, conjugate gradient still required many trial solutions (≈ 5, 000)
due to the need to calculate the gradient at each iteration (which requires one function
evaluation for each optimization parameter). Convergence of the genetic algorithm to the
same solution as the other two approaches (both gradient and simplex approaches converged
to nearly identical solutions for all direct surface optimization examples that were tested)
generally required 10 − 100 times more trial solution evaluations compared to the conjugate
gradient scheme. Thus the performance of the genetic algorithm was found to be very
poor due to slow convergence rates (the GA solution quality is low due to stoppage of the
optimization before complete convergence was reached; all routines were allowed to run for
a fixed number of function evaluations to provide a fair comparison). Similar behavior was
found for each example tested, providing further proof of the hypothesis that the number of
solution parameters is still too great for effective genetic algorithm optimization.
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Figure 5.21: Objective Function Convergence
A possible criticism of these tests is the fact that only one (or possibly just a few)
minima exist within the given search space. However, prior investigations by [63] have
shown that the solution space for complete radiation inverse planning problems is globally
convex when only minimum and maximum dose objectives are utilized. Therefore, this
investigation is completely applicable to full treatment planning analysis as the gradient
based approaches should perform equally well for any convex function (such schemes are
also guaranteed to converge to the global minima for fully convex functions [32]). Despite
the poor performance of the genetic algorithms in this area, their use is continued in the next
high parameter sensitivity study as such sensitivity changes often have a strong influence
on the performance of numerical optimization schemes. However, due to the consistent
out-performance of conjugate gradient over downhill simplex in these baseline studies, the
decision has been made to exclude the downhill simplex approach as a viable technique
for this work and the remaining efforts will focus solely on conjugate gradient and genetic
algorithm schemes.
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5.3.2

High Parameter Sensitivity Optimization

Much literature [63, 64] shows that gradient based solution approaches are often preferable
for inverse radiation treatment planning due to the convex shape of the majority of the
solution space, however, other works [65, 66] show that stochastic methods are preferable.
This next stage of research analysis attempts to discern the effects of increased parameter interaction and sensitivity on the performance of the conjugate gradient and genetic algorithm
optimization schemes in order to aid in determination of the most appropriate technique for
use with DCPO. Test case #2 from section 5.1.2 provides a reasonable challenge to planning
due to the closeness of the OAR and PTV. Abutting or nearly abutting situations such as
this represent the most difficult planning scenario, because a very steep dose gradient must
be achieved in the vicinity of the abutment. Thus, this case has been utilized as a primary
means of testing the optimization schemes herein. Also, one final cubic spline surface solution
is shown for this case to demonstrate the inapplicability of the scheme for DCPO (as these
type of abutting configurations often occur in real IMRT plans, this a somewhat realistic
test which clearly highlights the issues of cubic spline control, even for 2D cases). For
completeness an additional case is also presented in order to show that these findings can
indeed be generalized to other patient configurations.
This final performance analysis begins by computing plans for identical configurations
and prescriptions using both the genetic algorithm and conjugate gradient schemes. The
geometry for this case has been shown previously in Figure 5.5. For this analysis the
number of treatment beams has been reduced to five (equally spaced and coplanar) and
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the prescription has been modified slightly (note that the initial results for this problem
normalized the dose field to the point of maximum dose, however for the remainder of
this work the dose field is always normalized to the isocenter value): PTV target dose is
74 Gy (100%) with maximum dose of 77.7 Gy (105%) and minimum dose of 70 Gy (95%);
OAR is minimized with maximum allowable dose of 18 Gy (25%). The resulting dose fields
using a 10 cm beam with a NURB surface representation (control point spacing of 1.6 cm)
for both GA and gradient optimization schemes are given in Figure 5.22. The corresponding
dose volume histogram for each scheme is overlaid and shown in Figure 5.23. This DVH
comparison clearly shows that the gradient plan is better than the GA plan in terms of
PTV dose homogeneity (less cold spots and reduced hot spots) and OAR dose minimization.
While the rest-of-body (ROB) dose is slightly greater for a portion of the gradient plan, it
is not substantial enough to cause any concern.

(a) Genetic Algorithm

(b) Conjugate Gradient

Figure 5.22: Optimization Comparison: Relative Dose Fields
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Figure 5.23: Optimization Comparison: Dose Volume Histogram
It can be stated that the findings from the quality comparison of this one plan do not
justify the claim that the gradient based approach clearly out performs the GA. However,
upon analyzing the efficiency of each approach this claim cannot be disputed. Figure 5.24
shows a comparison of the general trends for the genetic algorithm and conjugate gradient
optimization schemes in terms of objective function value versus number of trial solutions
tested. While this figure shows only one particular run (roughly an average run of each), it
should be noted that the genetic algorithm never surpassed the average conjugate gradient
performance in any of the runs tested (over 10 runs of each case were tested using random
guess initialization for the gradient approach and a combination of random guess and fixed
input for the GA initialization).
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Figure 5.24: Objective Function Convergence for Full Planning Case
As mentioned previously, despite the ease of use and high quality of the cubic spline
interpolation approach, it has the major drawback of not providing an analytical means to
bound the resulting interpolation. It has been stated that this limitation eliminates the
use of this approach for DCPO, which was based largely on hypothetical situations. In
order to prove that such simulations were not unfounded and demonstrate the importance
of bounding within DCPO this planning case has been repeated again using the latest
optimization schemes with the cubic spline surface representation. While these results should
be comparable to those provided in Section 5.1.2, much higher quality is obtained here due to
the incorporation of overall beam weights and due to the increased efficiency of the numerical
optimizations (this allowed the solution to be computed to a higher degree of convergence
with less effort). Figure 5.25 shows the dose volume histogram for the cubic spline plan
(along with the NURB plan for comparison) which demonstrates the near equivalence of
the two procedures in terms of achievable plan quality. However, by analyzing the resulting
compensator surfaces in Figure 5.26 (only two of five are shown) one finds that the cubic
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spline surface required truncation in order to maintain the surface height above zero thickness
and the maximum below the linear accelerator tray limitation. The full cubic spline surface is
shown in the figure, with the areas of truncation highlighted in green. It should be noted that
the control points never dipped below zero, but the surface does, illustrating the importance
of a priori surface bounding as the resulting sharp internal corners would not be machinable.

Figure 5.25: Cubic Spline and NURB Surface Dose Volume Histograms

Figure 5.26: Cubic Spline and NURB Compensator Surface Comparison
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In order to demonstrate the general applicability and further prove the soundness of
the above observations another slightly more complex treatment planning case is presented.
This case represents a single slice from a typical measurement phantom (simulated patient
apparatus for dose measurements and experimentation) whereby a PTV with both convex
and concave boundaries is included, flanked by small circular organs-at-risk on either side.
The complete geometry is shown in Figure 5.27. The planning prescription is similar to that
used above with the PTV set at 100% dose (minimum 95% and maximum 105%), organ dose
minimized (maximum of 50% dose), and the ROB dose is minimized as well. Once again this
case was planned utilizing both the conjugate gradient and genetic algorithm approaches.
The resulting converged relative dose fields using five equally spaced, coplanar beams are
shown in Figure 5.28 and the DVHs are provided in Figure 5.29. The resulting compensator
shapes for each of the five fields are shown for both plans in Figure 5.30.

Figure 5.27: Two-Dimensional Phantom: Geometry
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(a) Genetic Algorithm

(b) Conjugate Gradient

Figure 5.28: Two-Dimensional Phantom: Relative Dose Fields

Figure 5.29: Two-Dimensional Phantom: Dose Volume Histogram
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Figure 5.30: Compensators for Gradient and GA Generated Treatment Plans
It can be seen from these results that the genetic algorithm (GA) plan is nearly the same
as that found using the conjugate gradient (CG) approach. This is evidenced by the shapes
of the resulting compensators for each scheme, DVHs, and relative dose fields. Figure 5.30
shows that for each corresponding beam, the compensator surfaces follow similar general
trends, reaching peaks and valleys at roughly the same locations and obtaining close to the
same modulation range for each. However, the objective function convergence (Figure 5.31)
once again shows that the GA required significantly increased numbers of trial solutions
(function evaluations) to reach the provided results. Also interesting to note is that the CG
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approach has now been supplemented by use of Broyden’s Jacobian estimation technique
(see Section 4.3), which significantly reduces the number of trial solutions needed to reach
a converged solution. Figure 5.31 highlights this added efficiency by showing typical results
for the CG technique, both with and without the use of Broyden’s method. In Figure 5.31b
it appears as if the standard conjugate gradient approach out performs that of Broyden’s
method. While this is true on an iteration count basis, it does not hold on a function
evaluation count (trial count) basis, as seen in Figure 5.31a. Since the evaluation of an entire
dose field is required for each trial solution, it is the trial count and not the iteration count
that is the most appropriate determinate of efficiency. Therefore, the trade-off in additional
iterations for less solution trials is quite worthwhile herein and Broyden’s approach was able
to bring about improved solution efficiency for all cases tested.

(a) All

(b) Gradient plus Broyden

Figure 5.31: Two-Dimensional Phantom: Objective Function Convergence
While these results combined with the added efficiency of Broyden’s method are likely
enough to absolutely recommend the use of gradient based techniques over genetic algorithms
for DCPO planning, one final study has been completed to finalize this claim. Since the
control parameter search space is very large, even in 2D, it is impossible to visualize the
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actual N -dimensional surface of the objective function (for this phantom case N = 155
control parameters are used, 15 NURBs control points and weights, plus one overall beam
weight per treatment beam). Therefore, the only means to reasonably view the solution space
is to utilize a series of one-dimensional plots for the control parameters (holding all others
constant). Figure 5.32 provides such plots for several arbitrarily chosen control parameter
directions at the point of solution convergence (i.e. using the final plan results shown above).
These plots all show that the local search space is not oscillatory and only contains a single
minima in each direction. While only a few plots are presented herein, a large quantity were
generated and tested throughout the course of this research, none of which have demonstrated
any different solution behavior. This consistent behavior significantly helps to justify the
claim that the overall search space contains only a single overall minima (i.e. the solution
surface is always convex). The claim of convexity was also proven mathematically by Deasy
[63] for the case of root-mean-square objective functions, which is nearly equivalent to the
linear plus quadratic objective used herein. The work of Deasy also concurs with the choice
of using gradient based optimization (when DVH constraints are not imposed) claiming that
convergence is achieved 1-2 orders of magnitude faster than with stochastic techniques, such
as the GA, for convex functions.
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Figure 5.32: One-Dimensional Search Space Plots

5.4

Development and Performance Summary

The results gathered above have allowed the determination of the most appropriate optimization scheme and also quantified the process of manufacturing constraining. These results have
brought about the observation that the genetic algorithm alone is not the ideal optimization
engine for this particular type of problem and have shown that gradient based approaches are
most suitable for IMRT inverse planning with DCPO. This observation is in agreement with
available literature which has shown that IMRT planning generally results in fully convex
objective functions [63]. In addition, the gradient optimization scheme has been accelerated
through the use of Broyden’s method, which eliminates the need to compute the gradient
directly at every iteration. This research has led to a final form of DCPO which therefore
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utilizes a conjugate gradient optimization technique, supplemented with Broyden’s method.
Additionally, the NURB surface control parameter limits have been explicitly quantified
through a detailed research study and analysis. This indirect control method has been
proven sufficiently adequate for providing nearly complete manufacturability of the IMRT
compensator surfaces. The next chapter makes use of this final optimized DCPO process and
presents results demonstrating the benefits of DCPO compared to current state-of-the-art
compensator treatment planning procedures.
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CHAPTER 6
RESULTS

The previous chapter has shown development and tuning of the Direct Compensator Profile
Optimization process. As the entire process has now been fully described and the most
efficient surface representation and optimization schemes have been found, this chapter is now
able to serve as a complete demonstration of this research work. This demonstration provides
specific examples which quantify the benefits and illustrate the utility and applicability of
DCPO for Intensity Modulated Radiation Therapy planning. First, an example from the
previous chapter is revisited and the solutions are compared to those obtained using a standard discrete beamlet optimization approach. This example provides data needed for several
important comparisons, including plan quality, compensator manufacturability, and inverse
planning (optimization) performance. In addition, this example serves to demonstrate the
reduced sensitivity to patient positioning errors provided by DCPO based planning. Then
a complete treatment plan is developed, using a real fully three-dimensional water phantom
configuration. This final case shows the applicability of DCPO for clinical work and should
demonstrate the readiness of the procedure for future commercial development.
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6.1

Discrete Beamlets vs. DCPO

This section continues the previously utilized two-dimensional phantom test case (see Figure 5.27) in order to provide a full comparison of DCPO against existing state-of-the-art
planning practices. This comparison is divided into three major areas of focus: plan quality,
manufacturing considerations, and patient positioning sensitivity.

6.1.1

Treatment Plan Comparison

In order to provide a realistic comparison between DCPO and standard planning approaches,
treatment plans for the phantom test case have been developed using a standard discrete
beamlet technique. Plans have been generated using both 10 mm and 5 mm sized beamlets,
requiring 85 and 160 optimization parameters, respectively. It should be noted that in
two-dimensions the parameter count comparison is very favorable for the standard beamlet
approach, but in three-dimensions this is not the case. For example, if this field were square
(15 cm×15 cm) a 5 mm beamlet approach would require 1285 optimization parameters, while
DCPO would require only 455 (10 mm spacing has been shown quite sufficient for DCPO).
Figure 6.1 shows contours of the resulting relative dose fields for both beamlet spacing values.
The dose field results do not show any significant differences, however, analyzing the
DVHs in Figure 6.2 clearly shows the superiority of the 5 mm plan (for example, 35% of the
right OAR receives 20% or greater dose for the 10 mm plan, while only 25% receives this
level for the 5 mm case, these values are 13% compared to 3% for the left OAR). Therefore, it
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is clear that the 5 mm plan is superior to the larger beamlet case. Therefore, the remainder
of this discussion will apply to the 5 mm plan, unless otherwise specified.
Although the plans are reasonably similar, it is observed that the standard beamlet
plans provide slightly better organ sparing, while achieving nearly identical tumor dose.
Therefore, it appears as if the beamlet plans are superior to those of DCPO, however, it
should be noted that the steep modulation gradients present in the beamlet plans are not
obtainable in practice due to delivery device limitations. Therefore, the quality of these plans
will be diminished once the compensators are smoothed and converted to manufacturable
shapes. The plans are therefore not truly comparable, since one (DCPO) is deliverable while
the other (beamlet) is not. This issue of deliverability is the main manufacturing concern and
is addressed in the following section, where these results are updated and this comparison is
repeated after inclusion of the effects of smoothing which is needed to produce machinable
compensator surfaces.

(a) 10 mm Beamlets

(b) 5 mm Beamlets

Figure 6.1: Beamlet Plan Dose Fields
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(a) Beamlet Plans Only

(b) Beamlet and DCPO

Figure 6.2: Beamlet vs. DCPO Dose Volume Histograms

6.1.2

Manufacturing Considerations

The section above has presented results comparing the quality of plans generated using
DCPO and standard beamlet approaches. Despite the slightly higher quality of the beamlet
based plans, the DCPO approach provides a major benefit: the complete manufacturability
of the resulting compensators. Thus the DCPO planned dose is exactly equivalent to the
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delivered dose (assuming that the dose calculation routines provide this level of accuracy).
This section describes the effects of manufacturability on the delivered dose field for the
beamlet approach, and highlights the plan degradation that is typical of approaches that
account for delivery device considerations after optimization.
Figure 6.3 shows the compensator thicknesses for the beamlet approach (note the staircase shape of the results) before smoothing along with those obtained using DCPO. It is
evident that the general trends are well preserved by DCPO and that DCPO results have an
inherent smoothness compared to those obtained using a direct beamlet approach. Figure
6.4 shows the beamlet based compensators smoothed to meet the previously determined
minimum machining requirements, as compared with the “ideal” planned compensators.
Additionally, the effects of the smoothing process on the dose field (i.e. the deliverable
dose) have been computed and the resulting DVHs are provided in Figure 6.5, along with
those before smoothing and with DCPO for comparison purposes. These results highlight
the typical plan degradation that results from smoothing the compensators to account for
machinability. It is noticed that the “ideal” discrete beamlet plans were slightly superior
in organ sparing compared with those generated using DCPO, however, after smoothing
the organ sparing became nearly equal but the PTV (tumor) dose has suffered a loss in
homogeneity (slight “cold” and “hot” spots now exist within the tumor region). This
behavior is common in after-the-fact delivery correction procedures and its avoidance is
a major benefit of the DCPO planning process.
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Figure 6.3: Beamlet vs. DCPO Compensator Surfaces

Figure 6.4: Smoothed Beamlet Compensator Surfaces
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(a) Discrete vs. Smoothed Beamlets

(b) Smoothed Beamlet vs. DCPO

Figure 6.5: Smoothed Beamlet and DCPO Dose Volume Histograms

6.1.3

Patient Positioning Sensitivity

An important point regarding the fluence modulation (and therefore compensator surface)
is that reducing unnecessary oscillations and increasing the surface smoothness substantially
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reduces the dosing error associated with patient positioning uncertainties. The effects of
smoothing the fluence modulation during planning (through beamlet parametrization) was
demonstrated by Markman et al [27] for the case of MLC based treatment planning. A
similar study was undertaken herein to prove that this applies equally well to DCPO and
compensator based planning with beamlet parametrization. Patient positioning errors are
simulated in this study by shifting the patient geometric data by some arbitrary amount and
analyzing the effects on the resulting dose distribution through a single forward calculation
using the DCPO optimized compensator surfaces. Using both the DCPO and direct beamlet
plans computed above, results have been generated and compared for shifts of 3 mm in each
of the positive and negative directions of each coordinate axis. The effects on the dose
field are completely straight forward since a homogeneous tissue assumption has been used
herein. These effects are quite difficult to visualize for the entire dose field, therefore only
dose volume histograms are included as they provide a more quantitative comparison of
these effects. The DVHs for the positive x-direction are shown in Figure 6.6. Specific data
points have been extracted for this positive x-direction as well as each of the remaining three
directions and are presented in Table 6.1. The data in this table shows that for three of the
four chosen directions the solution sensitivity is nearly equivalent, however, quite striking is
the positive x-direction shift, which shows a 12% reduction in PTV volume change for 96%
dose coverage. While this single case may not prove complete generality of this effect, when
combined with the similar findings of Markman et al [27] one finds sufficient evidence to
support the claim.
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(a) 5 mm Beamlets

(b) DCPO

Figure 6.6: Patient Positioning Error Analysis
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Table 6.1: DVH Comparison for Positioning Error (% Volume at Specified Dose)
Right OAR @ 20% Dose

Bixel

DCPO

Bixel

DCPO

Bixel

DCPO

Normal

88

85

3

13

26

33

+

PTV @ 96% Dose Left OAR @ 20% Dose

Shifted

56

65

16

26

12

21

x

Difference

-32

-20

+13

+13

-14

-12

-

Shifted

85

81

0

0

38.5

26

x

Difference

-3

-4

-3

-13

+12.5

-7

+

Shifted

88.5

85

2

14

32

40

y

Difference

+0.5

0

-1

+1

+6

+7

-

Shifted

85

85

8

9

27

32

y

Difference

-3

0

+5

-4

+1

-1

6.2

Full Patient Planning

This final example case is used to demonstrate the complete spectrum of performance
of the direct compensator profile optimization technique developed herein. The familiar
phantom example above is expanded to its true three-dimensional form. The contours of the
critical structures are shown in Figure 6.7, with one image containing labels naming each
of the structures. These contours were generated within a basic treatment planning system
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developed specifically for this research effort. The dose prescription is as follows: PTV target
dose is 100% (minimum 98% and maximum 102%), left and right organ doses are minimized
(maximum allowable dose is 45%), and the ROB dose is minimized as well. Five equally
space coplanar beams are again used.
The results for this full three-dimensional plan are shown in Figures 6.8 - 6.9, which
display the complete dose volume histograms and relative dose fields, respectively. The DVH
reveals that the plan is of good quality and shows that DCPO is a viable approach for IMRT
treatment planning. Two of the resulting five compensators are shown in Figure 6.11 for
illustrative purposes. The smoothness of these compensators reflects that of all five and show
that DCPO provides quality plans and machinable compensators. In addition, a complete
milling simulation analysis was performed on each of the five resulting compensators (one
such simulation is shown in Figure 6.12) yielding a maximum undercut of only 0.3 cm, which
clearly proves the high level of machinability that DCPO is able to obtain.

Figure 6.7: Full Patient Contours on Each Slice
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Figure 6.8: Full Patient Dose Volume Histogram

Figure 6.9: Full Patient Relative Dose Field (3D)
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Figure 6.10: Full Patient Relative Dose Field Slices

Figure 6.11: Full Patient Compensators (two of five shown)
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Figure 6.12: Compensator Milling Simulation Analysis
This chapter has provided detailed comparisons with existing treatment planning approaches, provided quantification of DCPO performance, as well as demonstrated the quality
achieved by the DCPO process for realistic treatment planning, all of which have been
completed with satisfactory results. These examples have provided an in-depth look at
DCPO and established the results necessary to prove its utility. Final observations and
conclusions regarding this research and directions for future extension of these ideas are
provided in the upcoming final chapter.
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CHAPTER 7
CONCLUSIONS

This research has provided the foundations for the first direct delivery parameter optimization scheme for solid compensator intensity modulated radiation therapy treatment
planning. This paper has highlighted the development of this innovative delivery parameter optimization scheme, named Direct Compensator Profile Optimization (DCPO). This
approach utilizes analytical Non-Uniform Rational B-spline (NURB) surfaces to represent
the compensator during IMRT inverse planning. These NURB surfaces have also been
appropriately limited, through a detailed milling constraint analysis, such that the allowable
compensator surfaces are completely machinable. The use of standard dose calculation
routines has been facilitated by discretization of the analytic surface into individual beamlets
whose strengths are provided by the corresponding compensator surface height. In addition,
the effects of this new approach on the performance of several numerical optimization schemes
has been quantified, and a standard conjugate gradient approach has been adopted as the
most suitable technique for the inverse planning process. Overall, the DCPO approach
has been shown to provide several advantages compared to conventional beamlet strength
optimization approaches while maintaining overall plan quality:
• less parameters are needed to accomplish the fluence modulation
• planned compensator surfaces are nearly 100% machinable using conventional threeaxis milling
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• effects of the delivery device on dose are included during inverse planning, with no
performance penalty
• planned patient dose more accurately reflects the actual deliverable patient dose
This research has demonstrated the performance of DCPO compared to other state-of-the-art
treatment planning approaches through direct numerical examples using various simulated
patient configurations. A thorough analysis of the benefits and limitations of DCPO has
been described showing that DCPO computed plans are comparable in quality to those
developed using conventional approaches, while providing the four major benefits listed
above. Additionally, it has been shown that the effects of patient positioning errors may be
reduced in some cases by use of DCPO.
Although rigorous verification testing was completed and presented herein, further
fine tuning of the various process steps may bring about additional performance benefits.
Specifically, several areas are recommended for continued development and exploration of
this technique. Possible research tasks, as well as a statement of focus for each of these areas
is provided below.
• NURB surface representation
– allow for non-uniform knot vectors
– allow for variable surface resolution
– explore the effects of allowing variable x and y coordinates for the control points
Determine how the overall optimization parameter count can be further reduced without sacrificing plan quality or surface machinability.
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• Inverse planning
– study the effects of prescriptions on plan quality
– incorporate dose-volume-constraints and analyze their effects on the solution space
– explore the effects of critical structure weighting on solution quality (possibly
Pareto optimal solutions) to assess planning trade-offs between organ sparing and
tumor dose homogeneity
Determine the feasibility of standardizing or automating dose prescriptions in order to
increase plan quality and robustness.
• Dose calculations
– incorporate more accurate dose calculation routines
– verify and test performance of DCPO for inhomogeneous tissue treatments
– increase the fidelity of the surface-to-fluence conversion process by allowing nonuniform/adaptive beamlet sizes
Determine if final plan quality is significantly improved by increasing dose calculation
accuracy during planning.
• Manufacturing
– incorporate high-speed machining simulation into the planning process (incorporate machine time into objective function)
– continue case study analysis to determine mass production appropriateness of
NURBs constraint parameters
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– expand the constraint analysis for the case of five-axis milling
Determine whether constraint refinement and adjustment will allow for improvements
in plan quality.

This research has introduced a new technique for the planning of Intensity Modulated
Radiation Therapy using solid compensators. Although several important areas of focus
have been listed for future exploration, this research has provided a fundamental start into
development of this promising new technique. It is hoped that future investigations can
continue this work and bring DCPO into the clinical setting, such that real patients can
benefit from the improved treatment plans that this approach is able to provide.
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